imipenem, anhydrous has been researched along with Cross Infection in 366 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 22 (6.01) | 18.7374 |
1990's | 63 (17.21) | 18.2507 |
2000's | 153 (41.80) | 29.6817 |
2010's | 120 (32.79) | 24.3611 |
2020's | 8 (2.19) | 2.80 |
Authors | Studies |
---|---|
Cornaglia, G; Koncan, R; Mazzariol, A; Roelofsen, E; Voss, A | 1 |
Cirioni, O; Della Vittoria, A; Giacometti, A; Kamysz, W; Nadolski, P; Riva, A; Scalise, G; Silvestri, C; Łukasiak, J | 1 |
Caniça, M; Ferreira, E; Leitão, J; Manageiro, V; Mendonça, N | 1 |
Cauda, R; Citton, R; D'Inzeo, T; Fadda, G; Fiori, B; Montuori, E; Posteraro, B; Sanguinetti, M; Spanu, T; Trecarichi, EM; Tumbarello, M | 1 |
Bonomo, RA; Endimiani, A; Hujer, AM; Hujer, KM; Luzzaro, F; Mantengoli, E; Migliavacca, R; Pagani, L; Rossolini, GM; Toniolo, A | 1 |
Avlami, A; Daikos, GL; Katsilambros, N; Kosmidis, C; Petrikkos, G; Psychogiou, M; Stefanou, I; Tassios, PT; Vasilakopoulou, A | 1 |
Castanheira, M; Jones, RN; Mendes, RE; Sader, HS; Toleman, MA; Walsh, TR | 1 |
Grosso, F; Peixe, L; Quinteira, S; Ramos, H | 1 |
Bulitta, JB; Drusano, GL; Glauner, AK; Kinzig-Schippers, M; Pfister, W; Sakka, SG; Sörgel, F | 1 |
Bonomo, RA; Decker, BK; Hujer, AM; Hujer, KM; Perez, F; Rather, PN | 1 |
Chen, M; Guo, P; Sun, H; Wang, H; Xu, Y; Yang, Q; Zhu, Y | 1 |
Bouza, E; Cercenado, E; Coll, P; Gutiérrez, O; Juan, C; Navarro, F; Oliver, A; Pérez, JL | 1 |
Gianneli, D; Loli, A; Miriagou, V; Tzelepi, E; Tzouvelekis, LS | 1 |
Bouallegue, O; Mansour, W; Nordmann, P; Poirel, L | 1 |
Chen, TL; Cho, WL; Fung, CP; Shaio, MF; Wu, RC | 1 |
Carrillo, B; Esparza-Ahumada, S; Garza-Ramos, U; Hernández, E; Jones, RN; Morfin-Otero, R; Rodriguez-Noriega, E; Sader, HS; Sanchez, A; Silva-Sanchez, J | 1 |
Badur, S; Cagatay, AA; Carrër, A; Eraksoy, H; Nordmann, P; Poirel, L | 1 |
Hsueh, PR; Huang, YT; Liao, CH; Lin, HY; Liu, CY; Yen, LC | 1 |
Afif, C; Bagattini, M; Daoud, Z; Di Popolo, A; Khan, AU; Triassi, M; Vitale, D; Zarrilli, R | 1 |
Adams-Haduch, JM; Doi, Y; Harrison, LH; Muto, CA; Pasculle, AW; Paterson, DL; Potoski, BA; Sidjabat, HE | 1 |
Acosta, J; Chaves, F; Juan, C; Oliver, A; Otero, JR; Sanz, F; Viedma, E; Zamorano, L | 1 |
Chung, DR; Ko, KS; Peck, KR; Son, JS; Song, JH; Suh, JY | 1 |
Chen, H; Chen, M; Sun, H; Wang, H; Xu, Y; Yang, Q | 1 |
De Luca, F; Docquier, JD; Ide, L; Nordmann, P; Poirel, L; Rossolini, GM; Verlinde, A | 1 |
Bulik, CC; Christensen, H; Nicolau, DP | 1 |
Ge, Y; Juan, C; Moya, B; Oliver, A; Pérez, JL; Zamorano, L | 1 |
Acosta, J; Beceiro, A; Bou, G; Chaves, F; Merino, M; Poza, M; Sanz, F | 1 |
Badal, RE; Baquero, F; Bouchillon, SK; Cantón, R; Hawser, SP; Hoban, DJ | 1 |
Bernabeu, S; Nordmann, P; Poirel, L; Revathi, G | 1 |
Chai, Z; Liu, H; Liu, J; Lu, J; Min, Z; Muhammad, M; Yang, Y; Zhang, L | 1 |
Ahmadi, A; Shahin, M | 1 |
Li, S; Liu, W; Mo, Q; Shao, M; Sun, L; Ying, N; Zhu, L | 1 |
Deng, Y; Huang, W; Li, J; Qiao, F; Zhang, W; Zhu, S; Zong, Z | 1 |
Bhattacharjee, A; Chakravarty, A; Chanda, DD; Paul, D | 1 |
Gholipour, A; Khaledi, M; Shahini Shams Abadi, M; Vafapour, R; Validi, M; Zamanzad, B | 1 |
Esmail, MAM; Khairy, RMM; Mahmoud, MS; Shady, RR | 1 |
Ebede, SO; Nwafia, IN; Ohanu, ME; Ozumba, UC | 1 |
Liu, B; Tong, S | 1 |
Gatermann, SG; Körber-Irrgang, B; Korte-Berwanger, M; Kresken, M; Pfennigwerth, N; Seifert, H | 1 |
Banerjee, T; Barman, H; Das, A; Kumar, A; Sharma, S; Yadav, G | 1 |
Fu, Y; Huang, G; Peng, Y; Tang, C; Yang, Y | 1 |
Chang, FY; Huang, LY; Li, JF; Lin, FM; Lin, JC; Siu, LK; Wang, CH; Yang, YS | 1 |
Chen, CH; Lin, CH; Lin, JS | 1 |
Gemperli, R; Gomez, DS; Levin, AS; Machado, AS; Oliveira, MS; Sanches, C; Santos, SRCJ; Silva Junior, CVD | 1 |
Badal, R; Cao, B; Chen, S; Chu, Y; Duan, Q; Feng, X; Gui, B; Hu, B; Hu, Z; Huang, W; Kong, H; Liao, K; Luo, Y; Ni, Y; Shao, H; Su, J; Sun, Z; Wang, Y; Wu, A; Xu, Y; Yang, Q; Yu, Y; Zhang, H; Zhang, S | 1 |
Amin, M; Dibachi, S; Shahin, M | 1 |
Ahmed, MO; Álvarez, R; Daw, MA; Elramalli, AK; Kieffer, N; Nordmann, P; Poirel, L | 1 |
Amara, M; Bedos, JP; Breton, N; Cavelot, S; Grimaldi, D; Merrer, J; Nebot, N; Neulier, C; Pangon, B; Tran-Dinh, A; Troché, G; Zuber, B | 1 |
Hao, D; Hu, Z; Liu, X; Sun, T; Tian, H; Wang, T; Wang, X | 1 |
da Silva, LP; da Silveira, M; de Oliveira Emídio, ZP; Fortaleza, CMCB | 1 |
Boral, B; Durmaz, R; Ergin, A; Eser, ÖK; Unaldi, Ö | 1 |
Azougagh, K; Barbier, F; Boulain, T; Boutrot, M; Guinard, J | 1 |
Kaniga, K; Lee, M; Redman, R; Rice, DA | 1 |
Chang, HL; Chang, HY; Chang, YF; Chi, CY; Ho, CM; Ho, MW; Lai, CH; Lin, CD; Lin, CW; Lin, HH; Lu, JJ; Teng, LJ; Tien, N; Tseng, SP | 1 |
Hsueh, PR; Lee, YT; Tsao, SM | 1 |
Bou, G; Castelo-Corral, L; Gutiérrez-Urbón, JM; Llinares, P; López-Calviño, B; Molina, F; Sousa, D | 1 |
Chen, TL; Dou, HY; Fung, CP; Huang, L; Kuo, SC; Lee, MH; Lee, YT; Yu, KW | 1 |
Badal, RE; Cao, B; Chen, M; Chu, Y; Duan, Q; Feng, X; Gui, B; Hu, B; Hu, Y; Hu, Z; Huang, W; Kong, H; Liao, K; Lu, J; Ni, Y; Shao, H; Shen, D; Su, J; Sun, Z; Wang, H; Wang, Y; Wu, A; Xu, Y; Yang, Q; Ye, H; Yu, Y; Zhang, H; Zhang, S | 1 |
Cardoso, O; Mendez, IP; Pereira, SG; Reis, T | 1 |
Cho, HH; Koo, SH; Kwon, KC; Sung, JY | 1 |
Bozkurt, F; Dal, T; Dayan, S; Deveci, Ö; Tekin, A; Tekin, R | 1 |
Chen, Z; Liu, P; Liu, S; Pei, D; Xue, X | 1 |
Alves, M; Bige, N; Canoui, E; Offenstadt, G; Tankovic, J | 1 |
Arslan, U; Kus, H; Tuncer, I; Turk Dagi, H | 1 |
Chongsuvivatwong, V; Chusri, S; Doi, Y; McNeil, E; Rivera, JI; Silpapojakul, K; Singkhamanan, K | 1 |
Han, J; Jung, JT; Kim, EY; Kim, HG; Kim, TW; Kwon, HH; Kwon, JG; Kwon, JS; Oh, JH | 1 |
Canet, P; Cavalcante, Rde S; Fortaleza, CM | 1 |
Balík, M; Lipš, M; Siller, M; Strojil, J; Suchánková, H; Urbánek, K | 1 |
Cardoso, O; Marques, M; Pereira, J; Pereira, SG | 1 |
Egea, P; Fernández-Cuenca, F; Galán-Sánchez, F; Guerrero-Lozano, I; Pascual, Á; Rodríguez-Iglesias, M | 1 |
Alcántar-Curiel, MD; Fernández-Vázquez, JL; García-Torres, LF; Gayosso-Vázquez, C; Giono-Cerezo, S; González-Chávez, MI; Jarillo-Quijada, MD; Morfín-Otero, R; Rodríguez-Noriega, E; Santos-Preciado, JI | 1 |
Ahn, S; Han, WD; Kim, ES; Kim, HB; Kim, NH; Kim, TS; Park, KU; Seo, HK; Shin, MJ; Song, KH; Yoo, JS | 1 |
Eser, F; Güner, HR; Güven, T; Kaya Kalem, A; Taşyaran, MA; Yilmaz, G | 1 |
Allou, N; Allyn, J; Augustin, P; Massias, L; Montravers, P; Welsch, C | 1 |
Ammari, H; Bakour, S; Olaitan, AO; Rolain, JM; Saoudi, K; Saoudi, S; Touati, A | 1 |
Chen, K; Li, M; Li, X; Ma, L; Wang, D; Wu, Z; Zhang, W | 1 |
Dong, D; Huang, L; Huang, S; Huang, Y; Li, H; Liu, W; Tong, Y; Wang, X; Wei, X; Yan, X; Yang, Z; Yuan, J; Zhao, X; Zou, D | 1 |
He, W; Huang, Y; Li, C; Li, J; Li, Y; Liu, X; Mao, P; Shan, J; Ye, D | 1 |
Fujita, T; Kawata, Y; Komatsu, M; Kondo, Y; Kubo, Y; Maehara, K; Migita, S; Murata, R; Nakamura, A; Sugimoto, K; Tanaka, S; Tanimoto, E; Yano, S | 1 |
Chang, CJ; Chen, CL; Chiu, CH; Huang, CW; Lee, HY; Wang, YH | 1 |
Culebras, E; García-Salguero, C; Picazo, JJ; Rodríguez-Avial, I | 1 |
Chia, JH; Hsu, PC; Kuo, AJ; Lee, CH; Lee, MH; Su, TY; Ye, JJ | 1 |
Bhadoria, AS; Jindal, A; Kumar, M; Maiwall, R; Sarin, SK | 1 |
Badal, RE; Cao, B; Chen, S; Chu, Y; Duan, Q; Feng, X; Gui, B; Hu, B; Hu, Z; Huang, W; Kong, H; Liao, K; Luo, Y; Ni, Y; Shao, H; Su, J; Sun, Z; Wang, Y; Wu, A; Xu, Y; Yang, Q; Yu, Y; Zhang, H; Zhang, S | 1 |
Chen, TL; Chern, J; Chou, CC; Lai, JH; Liang, SY; Liao, JH; Tsai, SF; Wu, SH; Wu, WL; Yang, JT | 1 |
Chongtrakool, P; Diraphat, P; Malathum, K; Pornsinchai, P; Siripanichgon, K | 1 |
Akalın, H; Heper, Y; İşçimen, R; Kahveci, F; Kelebek, N; Ocakoğlu, G; Özvatan, T; Sınırtaş, M; Yılmaz, E | 1 |
Badal, RE; Hackel, MA; Lob, SH; Sahm, DF | 1 |
Alnakshabandi, AA; Dlnya, A; Fatah, MH; Ganjo, AR; Goessens, W; Hammerum, AM; Kok, DJ; Kreft, D; Maghdid, DM; Mansoor, IY; Ng, K; Severin, JA; Verbrugh, HA | 1 |
Abdollahi, A; Aliramezani, A; Boroumand, MA; Douraghi, M; Ghalavand, Z; Ghourchian, S; Mohammadzadeh, M; Nateghi Rostami, M; Rahbar, M; Zeraati, H | 1 |
Damjanova, I; Fenyvesi, H; Jakab, G; Jánvári, L; Kovács, K; Melegh, S; Mestyán, G; Nyul, A; Szabó, H; Tóth, Á | 1 |
Aracil-García, B; Campos, J; Cuevas-Lobato, Ó; Fernández-Romero, S; Lara-Fuella, N; Oteo-Iglesias, J; Pérez-Grajera, I; Pérez-Vázquez, M | 1 |
Chmielewska, M; Cieplak, M; Hadzik-Blaszczyk, M; Krupa, R; Kur, Z; Lenartowicz, B; Wardyn, KA; Zycinska, K | 1 |
Culebras, E; López, MC; Picazo, JJ; Ríos, E; Rodríguez-Avial, I | 1 |
Bao, CM; Chen, FH; Chen, SM; Cui, EB; Huang, J; Li, T; Liu, X; Ning, NZ; Qu, F; Wang, H; Zhang, JL | 1 |
Abdeltwab, NM; El-Domany, RA; El-Magd, MA; Emara, M; Moustafa, WH | 1 |
Alp, E; Badal, R; Gulay, Z; Koksal, I; Korten, V; Lob, S; Mete, B; Mulazimoglu, L; Oguz, VA; Tabak, F; Unal, S; Yilmaz, G; Zarakolu, P | 1 |
Fang, X; Guo, J; Jin, Y; Liu, C; Pan, F; Qin, L; Yan, W | 1 |
Lipš, M; Neely, MN; Strojil, J; Suchánková, H; Urbánek, K | 1 |
Baker, S; Duong, HHT; Nga, TVT; Tuan Anh, N; Tuan, HM; Tuan, NS; Vinh Chau, NV; Y, DM | 1 |
Avlami, A; Daikos, GL; Giakkoupi, P; Hadjichristodoulou, C; Petrikkos, G; Polemis, M; Tzouvelekis, LS; Vatopoulos, A; Vourli, S; Zappas, S | 1 |
Harada, M; Nagasaki, Y; Shimono, N; Takuma, T; Tsuchimochi, N; Uchida, Y | 1 |
Chang, SC; Chen, CJ; Tsai, HT; Wang, JT | 1 |
Braun J, S; Castillo V, C; García C, P; González R, G; Labarca L, J; Lagos, M; Pérez I, A; Poggi M, H; Porte T, L; Román, JC; Romeo O, E | 1 |
Chen, YH; Hsu, HJ; Lee, MF; Peng, CF | 1 |
Casuccio, A; Cipolla, D; Corsello, G; Di Carlo, P; Mammina, C; Mazzola, A; Plano, MR; Tantillo, M | 1 |
Akinci, E; Balaban, N; Baran, G; Bodur, H; Cevik, MA; Erbay, A; Onguru, P | 2 |
Ben Redjeb, S; Mbarek, M; Meddeb, B; Messadi, Aa; Thabet, L; Turki, A | 1 |
Ascerić, M; Custović, A; Hadzić, S; Zulcić-Nakić, V | 1 |
Ariza, J; Dominguez, MA; Gavaldà, L; Gudiol, F; Manzur, A; Peña, C; Pujol, M; Suárez, C; Tubau, F | 1 |
Arunpan, P; Jamulitrat, S; Phainuphong, P | 1 |
Dal-Paz, K; Lima, AL; Oliveira, PR; Paula, AP; Rossi, F; Zumiotti, AV | 1 |
Cezário, RC; Costa-Pinto, RM; da Costa Darini, AL; Duarte De Morais, L; Ferreira, JC; Gontijo-Filho, PP | 1 |
Heard, M; Lautenbach, E; Marsicano, R; Serrano, S; Stieritz, DD; Tolomeo, P | 1 |
Kauermann, G; Kretzschmar, M; Mikolajczyk, RT; Sagel, U | 1 |
Balan, G; Lim, KT; Md Yasin, R; Thong, KL; Yeo, CC | 1 |
Restrepo, MI | 1 |
Amin, A | 1 |
Harris, AD; Hsiao, W; Johnson, JK; Lee, MS; Nataro, JP; Smith, G; Stine, OC; Venezia, RA | 1 |
Alves, I; Durocher, A; Grailles, G; Minacori, F; Nseir, S; Soury-Lavergne, A | 1 |
Catalano, M; Centrón, D; Di Martino, A; Famiglietti, A; Kaufman, S; Merkier, AK; Orman, B; Quiroga, C; Ramírez, MS; Ratier, L; Vay, C | 1 |
Faccone, D; Galas, M; López, Y; Maggi, G; Marcano, D; Pasterán, F; Payares, D; Rapoport, M; Salgado, N; Sánchez, D; Spadola, E; Ugarte, C | 1 |
Cady, A; Caroff, N; Corvec, S; Lepelletier, D; Lucet, JC; Marraillac, J; Reynaud, A | 1 |
Bartoszko-Tyczkowska, A; Gaszyński, W; Tyczkowska-Sieroń, E | 1 |
Bahram, F; Emaneini, M; Fatolahzadeh, B; Feizabadi, MM; Mehdi, FM; Mohammad, E; Morovat, T; Setareh, S; Soroush, S; Taherikalani, M | 1 |
Bilker, WB; Kim, M; Lautenbach, E; Schein, J; Synnestvedt, M; Vo, L; Weiner, MG | 1 |
Alba, J; Belmonte, O; Drouet, D; Jaffar-Bandjee, MC; Kuli, B; Lugagne-Delpon, N; Moiton, MP; Mourlan, C | 1 |
Fugazza, G; Giacobone, E; Landini, P; Migliavacca, R; Navarra, A; Nucleo, E; Pagani, L; Steffanoni, L | 1 |
Chen, CL; Chia, JH; Chiu, CH; Lee, HY; Liu, SY; Su, LH; Tseng, LY | 1 |
Piyasirisilp, S; Premprawat, W; Thamlikitkul, V | 1 |
Dizbay, M; Hizel, K; Sezer, BE; Tunccan, OG | 1 |
Daikos, GL; Douzinas, E; Legakis, NJ; Miriagou, V; Tsakiri, M; Tzelepi, E; Tzouvelekis, LS; Zioga, A | 1 |
Culebras, E; Gómez, M; González-Romo, F; Head, J; Morales, G; Picazo, JJ | 1 |
Harris, AD; Hsiao, WW; Johnson, JK; Rasko, DA; Stine, OC; Thom, KA | 1 |
Chuang, YC; Cooper, CA; Dartois, N; Datsenko, O; Dukart, G; Dzyublik, O; Freire, AT; Gandjini, H; Glumcher, F; Kim, MJ; Korth-Bradley, JM; Maroko, RT; Melnyk, V | 1 |
Chong, Y; Kim, JJ; Kim, S; Koh, E; Lee, CH; Lee, J; Lee, K; Lee, MA; Roh, KH; Yong, D | 1 |
Arlet, G; Boutelier, C; Carbonne, A; Castaing, D; Decre, D; Dussaix, E; Gastiaburu, N; Guerin, C; Jarlier, V; Kassis-Chikhani, N; Lavigne-Kriaa, A; Neuville, S; Saliba, F; Samuel, D; Sengelin, C | 1 |
Furtado, GH; Gales, AC; Medeiros, EA; Perdiz, LB; Santos, AE; Wey, SB | 1 |
Cai, J; Liu, J; Wu, D | 1 |
Astagneau, P; Carbonne, A; L'Hériteau, F; Lacavé, L; Miliani, K | 1 |
Chung, DR; Ha, YE; Joo, EJ; Kang, CI; Kang, SJ; Lee, NY; Park, SY; Peck, KR; Song, JH | 1 |
Flamm, RK; Korten, V; Laeuffer, JM; Morrissey, I; Mutters, R; Nordmann, P; Picazo, JJ; Quintana, A; Seak, JC | 1 |
Eagye, KJ; Nicolau, DP | 1 |
Huang, ML; Kuo, HY; Lin, MF; Liou, ML; Sung, CH; Tu, CC; Yang, CM; Yeh, HW | 1 |
Hong, KW; Jeong, H; Kang, MW; Kim, SI; Kim, YJ; Kim, YR; Park, YJ; Wie, SH | 1 |
Baron, R; Boles, JM; Bourigault, C; Cosse, M; Daniel, L; Garlantézec, R; Jourdain, S; Le Du, I; Lefevre, M; Lejeune, B; Lelay, G; Prat, G; Renault, A; Tande, D; Tonnelier, JM; Virmaux, M | 1 |
Akalın, H; Akova, M; Arman, D; Aygen, B; Başaran, S; Bayramoğlu, G; Dizbay, M; Dokuzoğuz, B; Eraksoy, H; Esener, H; Hasçelik, G; Köksal, I; Korten, V; Oğünç, D; Sınırtaş, M; Söyletir, G; Sümerkan, B; Tünger, A; Ulusoy, S; Yalçın, AN | 1 |
Altunsoy, A; Aypak, C; Azap, A; Balık, I; Ergönül, Ö | 1 |
Ajao, AO; Comer, AC; Furuno, JP; Harris, AD; Johnson, JK; McGregor, JC; Moore, AC; Morgan, DJ; Thom, KA | 1 |
Doi, M; Kobayashi, K; Koda, S; Kumon, H; Kusano, N; Kuwabara, M; Shimizu, E; Shimizu, W; Sugai, M | 1 |
Choi, JY; Jung, SI; Kim, DH; Kim, SH; Ko, KS; Park, KH; Park, YK | 1 |
Bustamante, Z; Fernández, E; Gallego, L; Rosales, I; Sevillano, E; Umaran, A; Zabalaga, S | 1 |
Jung, SI; Kim, SH; Ko, KS; Park, KH; Park, YK | 1 |
Amine, S; Ben Redjeb, S; Boutiba-Ben Boubaker, I; Ghozzi, R; Hammami, S; Saidani, M | 1 |
Aleksandrova, IV; Borisova, LA; Chernen'kaia, TV; Kosolapov, DA; Vorob'eva, TIu | 1 |
Chen, CP; Chen, TL; Cho, WL; Fung, CP; Lee, YT; Wang, FD | 1 |
Tomoda, H | 1 |
Decker-Burgard, S; Laeuffer, J; Morrissey, I; Mutters, R; Seifert, H; Valenza, G | 1 |
Choi, SH; Chung, J; Hong, SB; Jang, HJ; Kim, JW; Koh, Y; Lim, CM | 1 |
Anderson, DJ; Bennett, KM; Dotson, TL; Sarraf-Yazdi, S; Sharpe, M; Vaslef, SN | 1 |
Choi, EH; Hong, KB; Kang, DK; Kim, EC; Lee, HJ; Lim, JH; Oh, HS; Park, JD; Son, IS; Song, JS | 1 |
Farajnia, S; Higgins, PG; Nahaei, MR; Peymani, A; Seifert, H | 1 |
Aleo, A; Bonura, C; Brunelli, T; Degl'Innocenti, R; Fasciana, T; Mammina, C; Nastasi, A; Pesavento, G | 1 |
Bansal, N; Chander, J; Gupta, V; Singla, N | 1 |
Alberti, S; Beceiro, A; Cabot, G; Juan, C; Moyá, B; Oliver, A; Zamorano, L | 1 |
Chander, J; Gupta, V; Sidhu, S | 1 |
Ozseven, AG; Ozseven, L; Sesli Çetin, E | 1 |
Chen, TL; Dou, HY; Fung, CP; Hsueh, PR; Huang, L; Kuo, SC; Lee, MH; Lee, YT; Su, IJ; Yu, KW | 1 |
Chang, SC; Dong, SX; Wang, JT | 1 |
Liu, CF; Song, WL; Sun, Y; Wang, LJ; Zhang, ZJ | 1 |
Cervia, JS | 1 |
Choi, EH; Hong, KB; Lee, HJ | 1 |
Artiaco, S; Bellomo, F; Bianchi, P; Cicero, G | 1 |
Berktaş, M; Ceylan, MR; Cıkman, A; Karahocagil, MK; Parlak, M | 1 |
Arpin, C; Bezian, MC; Dubois, V; Gachie, JP; Gavinet, AM; Maire, JP; Menard, F; Quentin, C; Rogues, AM | 1 |
Correia, M; Da Silva, GJ; Duarte, A; Leitão, R; Peixe, L; Ribeiro, G; Sousa, JC; Vital, C | 1 |
Costa, SF; Levin, AS; Levy, CE; Manrique, AE; Medeiros, EA | 1 |
Chen, P; Cheng, WC; Xiang, XD; Zan, JN | 1 |
Mikamo, H; Tamaya, T; Yin, XH | 1 |
Benomar, S; Bouharrou, A; Habzi, A; Lahbabi, M; Najdi, T; Nejjari, N; Zerhouni, F | 1 |
Boulanger, BR; Fogarty, C; Fowler, C; Kahn, JB; Morgan, N; Oross, M; Tennenberg, A; West, M; Wiesinger, B; Wu, SC | 1 |
Burgmann, H | 1 |
Chen, MJ; Wang, H | 1 |
Maharwal, S; Sharma, M; Taneja, N | 1 |
Cimiotti, J; Della-Latta, P; Gupta, A; Larson, E; Loughrey, M; Rubenstein, D; Saiman, L; Stone, PW | 1 |
Abdallah, VO; Brito, DV; Gontijo Filho, PP; Matos, C; Oliveira, EJ | 1 |
Alvarez-Lerma, F; Blanco, A; Domínguez-Muñoz, JE; Gener, J; Maraví-Poma, E; Olaechea, P | 1 |
Aymon, D; Bally, F; Bille, J; Chiolero, R; Cometta, A; Garbino, J; Glauser, MP; Greub, G; Kinge, T; Krawczyk, L; Lew, D; Romand, JA; Rubinstein, E; Schaller, MD; Stratchounski, L; Zanetti, G | 1 |
Benjamin, WH; Chavers, LS; Chavers, P; Funkhouser, E; Moser, SA; Stamm, AM; Waites, KB | 1 |
Choi, SH; Chung, JW; Hyong Kim, T; Kim, NJ; Kim, YS; Lee, SO; Ryu, J; Woo, JH | 1 |
Hiyama, E; Kodaira, M; Sasaki, M; Sueda, T; Takesue, Y; Yokoyama, T | 1 |
Qian, YS; Xiao, GX; Zhuo, C | 1 |
Cao, B; Chen, M; Sun, H; Wang, H; Zhu, Y | 1 |
Kong, HS; Xu, GY; Xu, XW; Yang, Q; Yu, YS; Zhong, BY | 1 |
Bértolo, E; Da Silva, GJ; Duarte, A; Gallego, L; Peixe, L; Quinteira, S; Sousa, JC | 1 |
Calvo, F; Canduela, MJ; Gallego, L; Martín, G; Pujana, I; Sevillano, E; Umaran, A | 1 |
Manzar, S | 1 |
Cirioni, O; D'Amato, G; Giacometti, A; Kamysz, W; Lukasiak, J; Scalise, G; Silvestri, C; Simona Del Prete, M | 1 |
Bernabeu-Wittel, M; García-Curiel, A; Jiménez-Mejías, ME; Pachón, J; Pachón-Ibáñez, ME; Pichardo, C | 1 |
Chong, Y; Ha, GY; Jang, SJ; Kang, JO; Kim, JJ; Lee, K; Shin, BM; Yong, D | 1 |
Berry, N; Burnie, JP; Eddleston, J; Hassan, I; Kirby, A; Majumdar, S; Williams, C | 1 |
Brink, AJ; Feldman, C; Grolman, DC; Muckart, D; Pretorius, J; Richards, GA; Senekal, M; Sieling, W | 1 |
Bal, C; Bauernfeind, A; Ersöz, G; Otağ, F; Salcioğlu, M; Schneider, I | 1 |
Dubouix, A; Héritier, C; Marty, N; Nordmann, P; Poirel, L | 1 |
Cruz, RP; Goldani, LZ; Zavascki, AP | 1 |
Li, DJ; Liu, WL; Sun, ZY; Zhu, XH | 1 |
Antonopoulou, A; Giamarellos-Bourboulis, EJ; Giamarellou, H; Kentepozidis, N; Plachouras, D; Tsaganos, T | 1 |
Arnal, JM; Berger, P; Franceschini, B; Gainnier, M; Michel, F; Papazian, L; Sainty, JM | 1 |
Kollef, MH; Shorr, AF; Susla, GB | 1 |
Jackson, WL; Kollef, MH; Ramage, AS; Shorr, AF; Tennenberg, AM; Wu, SC; Zadeikis, N | 1 |
Akinci, E; Balaban, N; Bodur, H; Colpan, A; Erbay, A | 1 |
Aldabó-Pallás, T; Cayuela, A; Fernández-Hinojosa, E; Garcia-Curiel, A; Garnacho-Montero, J; Jiménez-Jiménez, FJ; Marquez-Vácaro, JA; Ortiz-Leyba, C | 1 |
Benbachir, M; Benchekroun, S; Harif, M; Loukili, A; Mahmal, L; Quessar, A | 1 |
Bastos, CC; Kokis, VM; Long, JB; Moreira, BM; Pellegrino, FL; Santos, KR; Silva, MG | 1 |
Bae, IK; Jeon, BC; Jeong, SH; Kwon, SB; Lee, JH; Lee, K; Lee, SH; Song, JS; Young, D | 1 |
d'Escrivan, T; Devos, P; Dubreuil, L; Georges, H; Kipnis, E; Leroy, O | 1 |
Beceiro, A; Bou, G; Canle, D; Cartelle, M; Cisneros, JM; del Mar Tomas, M; Llinares, P; Molina, F; Pertega, S; Villanueva, R | 1 |
Akcay, MN; Altoparlak, U; Erol, S; Ertek, M; Ozkurt, Z | 1 |
Alba, J; Ishii, Y; Kimura, S; Matsushima, Y; Shiroto, K; Watanabe, K; Yamaguchi, K | 1 |
Aubron, C; Collet, L; Fortineau, N; Nicolas, P; Nordmann, P; Poirel, L | 1 |
Kuti, JL; Nicolau, DP; Sun, HK | 1 |
Bou, G; Cisneros, JM; Fernández-Cuenca, F; Martínez-Martínez, L; Pachón, J; Pascual, A; Ribera, A; Rodríguez-Baño, J; Vila, J | 1 |
Bar, K; Bearman, GM; Edmond, MB; Marra, AR; Wenzel, RP | 1 |
Han, K; Hong, SB; Kim, J; Lee, J; Shin, HS; Shin, KS; Son, BR; Youn, SJ | 1 |
Manolis, EN; Metzidie, E; Pournaras, S; Sofianou, D; Tsakris, A | 1 |
Alvarez-Lerma, F; Castillo, F; Cerdá, E; Insausti, J; Martínez-Pellús, A; Olaechea, P; Palomar, M | 1 |
Jin, ZJ; Li, CR; Luo, L; Peng, SH | 1 |
Chiu, CH; Chu, C; Lin, JY; Lin, TY; Liu, SY; Su, LH | 1 |
Agodi, A; Anzaldi, A; Barchitta, M; Di Popolo, A; Ghiraldi, E; Mattaliano, A; Travali, S; Zarrilli, R | 1 |
Cooper, A; Joshi, M; Kassira, W; McCarthy, M; Metzler, M; Olvey, S | 1 |
Luczak, M; Pszenna, M; Rokosz, A | 2 |
Luczak, M; Marchel, H; Rudnicka, J; Wroblewska, MM | 1 |
Biswas, D; Prasad, R; Sarkar, B; Sharma, JP | 1 |
Katsifa, H; Kontodimou, A; Polemis, M; Tsorlini, H; Tzouvelekis, LS; Vatopoulos, AC; Vourli, S | 1 |
Antachopoulos, C; Benos, A; Katragkou, A; Kotsiou, M; Roilides, E; Sofianou, D; Tamiolaki, M | 1 |
Bille, J; Bugnon, D; Cotting, J; Décosterd, L; Giannoni, E; Majcherczyk, P; Moessinger, A; Moreillon, P; Zanetti, G | 1 |
Leitner, E; Lode, H; Schmitt, DV; Welte, T | 1 |
Bilker, WB; Fishman, NO; Lautenbach, E; Nachamkin, I; Sheridan, A; Weiner, MG | 1 |
An, YJ; Bae, IK; Jang, SJ; Jeong, SH; Lee, K; Lee, SH; Park, KO; Sohn, SG; Sung, KH; Yang, KS; Young, D | 1 |
Abbassi, MS; Achour, W; Ben Hassen, A; Cherif, A; Jabnoun, S; Khrouf, N | 1 |
Bonello, M; Dell'Aquila, R; Loreto, PD; Nalesso, F; Rodighiero, MP; Ronco, C; Spanò, E | 1 |
Bornemann, R; Krämer, A; Kretzschmar, M; Mikolajczyk, RT; Sagel, U | 1 |
An, HG; Jeon, SS; Kang, IS; Yu, SM | 1 |
Bergès, L; Deplano, A; Rodriguez-Villalobos, H; Struelens, MJ | 1 |
Fujiue, Y; Gotoh, N; Hayashida, S; Itaha, H; Kadono, M; Kashiyama, S; Kohara, T; Komatsuzawa, H; Kouda, S; Kuwabara, M; Ohara, M; Onodera, M; Sasaki, M; Sugai, M; Usui, T; Yokoyama, T | 1 |
Chen, YG; Li, LJ; Yang, Q; Yu, YS; Zhou, H | 1 |
Melzer, M; Petersen, I | 1 |
Adams, J; de Oliveira Garcia, D; Doi, Y; Ghilardi, AC; Paterson, DL | 1 |
Bilewska, A; Luczak, M; Młynarczyk, A; Młynarczyk, G; Pupek, J | 1 |
Doroszkiewicz, W; Kakol, A; Korzekwa, K; Wojnicz, D | 1 |
Ng, SY; Poh, K; Tan, TY | 1 |
Bennett, KM; Dodds-Ashley, E; Hayward, TZ; Kaye, KS; Scarborough, JE; Sharpe, M; Vaslef, SN | 1 |
Akova, M; Altun, B; Gürkan Aydin, N; Hasçelik, G; Metan, G; Zarakolu, P | 1 |
Li, LJ; Wei, ZQ; Yang, Q; Yu, YS; Zhou, H | 1 |
Barth, AL; Gaspareto, PB; Martins, AF; Zavascki, AP | 1 |
Jamulitrat, S; Suwalak, N; Thongpiyapoom, S | 1 |
Deptuła, A; Gierlotka, K; Gospodarek, E; Michalska, A | 1 |
Levi, K; Towner, KJ; Vlassiadi, M | 1 |
Basustaoglu, A; Eraksoy, H; Korten, V; Kurt, H; Ozturk, R; Ulusoy, S; Yaman, A; Yuce, A; Zarakolu, P | 1 |
Grundmann, H; Jonas, D; Meyer, E; Schwab, F | 1 |
Fridkin, SK; Hayden, MK; Lolans, K; Mueller, MR; Phillips, L; Quinn, JP; Warren, DK | 1 |
Joseph, J; Rodvold, KA | 1 |
Ivanov, DV | 1 |
Dowzicky, M; Kuti, JL; Nicolau, DP | 1 |
Diomidous, M; Ikonomidis, A; Markou, F; Poulou, A; Pournaras, S; Spanakis, N; Tsakris, A; Vrizas, D | 1 |
Levin, AS; Moretti, ML; Oliveira, HB; Pereira, GH | 1 |
Pranada, F; Pusztai-Markos, Z | 1 |
Gutiérrez-Núñez, J; Harrington, PT; Ramirez-Ronda, CH | 1 |
Härmä, M; Köljalg, S; Lyytikäinen, O; Vuopio-Varkila, J | 1 |
Başustaoğlu, AC; Baysallar, M; Gün, H; Haznedaroğlu, T; Saraçli, MA | 1 |
Giamarellos-Bourboulis, EJ; Giamarellou, H; Grecka, P | 1 |
Eller, J; Hamacher, J; Lode, H; Schaberg, T | 1 |
Lacey, SL; Want, SV | 1 |
Harris, SP; Muder, RR; Nguyen, MH; Pasculle, AW | 1 |
Brun-Buisson, C; Chemineau, V; De Gatines, G; Duval, J; Legrand, P; Tankovic, J | 1 |
Jones, RN; Marshall, SA | 1 |
Burns, J; Eisner, W; Go, ES; Kreiswirth, B; Mariano, N; Mosinka-Snipas, K; Rahal, JJ; Urban, C | 1 |
Baumgartner, JD; Chopart, P; Cometta, A; Eggimann, P; Herter, C; Huber, O; Lew, D; Pittet, D; Schaad, U; Zimmerli, W | 1 |
Reboli, AC; Wood, CA | 1 |
Bello, H; Dominguez, M; Garcia, A; Gonzalez, G; Mella, S; Zemelman, R | 1 |
Spencer, RC | 1 |
Finch, RG; Glauser, M; Norrby, SR | 1 |
de Champs, C; Gazuy, N; Guelon, D; Henquell, C; Sirot, D; Sirot, J | 1 |
Avraham, I; Berger, BJ; Go, E; Mariano, N; Rahal, JJ; Rubin, D; Urban, C | 1 |
Babalova, M; Blahová, J; Hupková, M; Krcméry, V; Schäfer, V | 1 |
Ayers, LW; Barnishan, J; Fass, RJ | 1 |
Bastian, A; Bestehorn, K; Büchele, G; Gaus, W; Laubenthal, HJ; Rodloff, AC | 1 |
Baldassarre, R; Comunale, L; Poletti, G; Tallarigo, C | 1 |
Grausova, S; Koren, P; Krcmery, V; Krupova, I; Kukuckova, E; Kunova, A; Lacka, J; Spanik, S; Trupl, J | 1 |
Blahová, J; Králiková, K; Krcméry, V; Kubonová, K | 1 |
Archibald, L; Gaynes, R; McGowan, JE; Monnet, D; Phillips, L; Tenover, F | 1 |
Carmeli, Y; Samore, MH | 1 |
Cheadle, WG; Fabian, T; Fry, DE; Gardner, SA; Kesterson, L; Livingston, DH; Malangoni, MA; Polk, HC; Trachtenberg, LS | 1 |
Cetron, MS; Crane, GL; Finelli, L; Jarvis, WR; Paul, SM; Tokars, JI | 1 |
Garau, J; Martínez Lacasa, J | 1 |
Blanquer, J; Cobo, L; Corcia, S; Daguerre, M; de Latorre, FJ; Del Nogal, F; Garau, J; León, C; Net, A; Rello, J | 1 |
Adhikari, M; Pillay, DG; Pillay, T; Sturm, AW | 1 |
Eltahawy, AT | 1 |
Aleksandrova, IA; Grudinina, SA; Rezvan, SP; Sidorenko, SV; Sterkhova, GV | 1 |
Modakkas, EM; Sanyal, SC | 1 |
Blahová, J; Králiková, K; Krcméry, V; Mlynarcík, D; Trupl, J | 1 |
Burns, JM; Dominick, D; Freeman, K; Horn, D; Lim, M; Mariano, N; Marks, S; Maurer, J; Rahal, JJ; Segal-Maurer, S; Urban, C | 1 |
Ambrosetti, P; Aymon, D; Bille, J; Chiolero, R; Cometta, A; Glauser, MP; Harbarth, S; Huber, O; Jaccard, C; Lew, D; Praz, G; Ricou, B; Romand, J; Schneider, R; Troillet, N; Zanetti, G | 1 |
Allerberger, F; Bauernfeind, A; Dierich, MP; Eberlein, E; Fille, M; Jungwirth, R; Schneider, I; Speer, G | 1 |
Rokosz, A; Sawicka-Grzelak, A | 1 |
Arbo, MD; Barefoot, L; Hariharan, R; Nathan, C; Snydman, DR; Weinstein, RA | 1 |
Igari, J; Nakamura, A; Oguri, T; Tabe, Y | 1 |
Caldwell, JW; Johnson, RH; Singh, S | 1 |
Carmeli, Y; DeGirolami, P; Samore, MH; Troillet, N; Venkataraman, L | 1 |
Iakovlev, SV | 1 |
Deblangy, C; Decré, D; Fichelle, A; Joly-Guillou, ML; Kosmann, MJ; Lucet, JC; Pernet, M; Régnier, B | 1 |
Zafar, A | 1 |
Barbarini, D; Carretto, E; Emmi, V; Marone, P; Marzani, FC; Poletti, F | 1 |
Bou, G; Cerveró, G; Domínguez, MA; Martínez-Beltrán, J; Quereda, C | 2 |
Fridkin, SK; Gaynes, RP; Hubert, SK; Lawton, R; McGowan, JE; Steward, CD; Tenover, FC; Wallace, D | 1 |
Alvarez-Lerma, F; Bauer, TT; Blanquer, J; Castillo, F; Leal-Noval, SR; León-Gil, C; Martínez-Pellús, A; Nadal, P; Palomar, M; Ros, F; Torres, A | 1 |
Decré, D; Deleuze, A; Desmonts, JM; Fierobe, L; Joly-Guillou, ML; Lucet, JC; Mantz, J; Muller-Serieys, C | 1 |
Becerril, B; Caballero-Granado, FJ; Cisneros, JM; Cuberos, L; Moreno, I; Pachón, J | 1 |
Bello, H; Cerda, F; Domínguez, M; González, G; Mella, S; Sepúlveda, M; Zemelman, R | 1 |
Combest, A; Mariano, N; Rahal, JJ; Segal-Maurer, S; Sorin, M; Urban, C | 1 |
Salaria, M | 1 |
Amyes, SG; Atay, T; Gülay, Z | 1 |
Badolati, A; Fontán, PA; Gammella, D; Maskin, B; Spinedi, EG | 1 |
Barth, AL; de Freitas, AL | 1 |
Benedetto, G; Enrichens, F; Franchello, A; Mao, P; Olivero, G; Olivero, S; Sciascia, C | 1 |
De Rose, V; Pozzi, E | 1 |
Aresu, G; Ceccio, S; Garau, G; Melis, S; Morini, M; Palomba, A; Pautasso, M; Piu, G | 1 |
Casiraghi, S; Caspani, P; Germiniani, R; Pace, M; Rosina, M; Tajana, A; Trabucchi, E | 1 |
Culver, DH; Gaynes, RP | 1 |
Shimada, K | 1 |
Aubert, G; Boylot, D; Brunon, J; Dorche, G; Duthel, R; Jacquemond, G; Pozzetto, B | 1 |
Bengel, D; Przechera, M; Risler, T | 1 |
Hamon-Poupinel, V; Le Coutour, X; Malbruny, B; Vergnaud, M | 1 |
Beaucaire, G; Beuscart, C; Caillaux, M; Chidiac, C; Karp, P; Leroy, O | 1 |
Bercault, N; Demasure, M; Gueveler, C; Martin, P; Poisson, D | 1 |
Norrby, SR | 1 |
Asmus, S; Bodmann, KF; Hartenauer, U; Koch, EM; Ritzerfeld, WW; Weilemann, LS | 1 |
Fujita, J; Higuchi, K; Irino, S; Nakano, M; Negayama, K; Yamaji, Y | 1 |
Bale, MJ; Doebbeling, BN; Pfaller, MA; Wenzel, RP | 1 |
Duval, J; Soussy, CJ | 1 |
Matsumoto, K; Nagatake, T | 1 |
Bechrakis, P; Bilalis, D; Giamarellou, H; Mandragos, K; Pigas, K; Sfikakis, P | 1 |
Bodey, GP; Elting, LS; Fainstein, V; Khardori, N | 1 |
Antal, M; Knothe, H; Krcméry, V; Seginková, Z | 1 |
Avril, JL; Bousser, J; Donnio, PY; Hercouet, H | 1 |
Kahan, F; Kropp, H | 1 |
Delzell, D; Kabins, SA; Nathan, C; Weinstein, RA | 1 |
Baratta, E; Bucaneve, G; Del Favero, A; Grignani, F; Menichetti, F; Pasticci, MB; Patoia, L | 1 |
Forder, AA; Linton, DM; Plumb, H; Potgieter, PD | 1 |
Alvarez, ME; Bodey, GP; Hsu, KC; Rolston, KV | 1 |
Citron, DM; Goldstein, EJ | 1 |
Roselle, GA | 1 |
Bure, AM; Laisne, MJ; Pangon, B; Regnier, B; Rouveix, E; Vachon, F; Wolff, M | 1 |
Daikos, GK; Galanakis, N; Giamarellou, H; Sfikakis, P; Voutsinas, D | 1 |
Santos-Ferreira, MO; Vital, JO | 1 |
Bertch, K; Foster, TS; Rapp, RP; Tibbs, P; Young, B | 1 |
Cumberland, NS; Jones, KP | 1 |
Bergogne-Bérézin, E; Joly-Guillou, ML | 1 |
Forst, H; Lenhart, FP; Ruckdeschel, G; Unertl, K | 1 |
Duma, RJ; Gebhart, RL; Groschel, DH; Mandell, GL; Palmer, DL; Salata, RA; Scheld, WM; Wade, BH; Wenzel, RP | 1 |
Starr, SE | 1 |
11 review(s) available for imipenem, anhydrous and Cross Infection
Article | Year |
---|---|
Global challenge of multidrug-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Humans | 2007 |
[Mode of action of microbial anti-MRSA agents].
Topics: Acetylcysteine; Alkyl and Aryl Transferases; Anti-Bacterial Agents; Cross Infection; Diterpenes; Drug Design; Drug Resistance, Bacterial; Drug Synergism; Imipenem; Methicillin-Resistant Staphylococcus aureus; Mycotoxins; Spiro Compounds | 2012 |
Appropriate use of the carbapenems.
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Carbapenems; Cilastatin; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Drug Utilization; Ertapenem; Humans; Imipenem; Lactams; Meropenem; Patient Selection; Pneumonia, Bacterial; Practice Patterns, Physicians'; Protease Inhibitors; South Africa; Surgical Wound Infection; Thienamycins; Urinary Tract Infections | 2004 |
Quinolones for treatment of nosocomial pneumonia: a meta-analysis.
Topics: Anti-Infective Agents; Cilastatin; Ciprofloxacin; Cross Infection; Humans; Imipenem; Levofloxacin; Meta-Analysis as Topic; Ofloxacin; Pneumonia, Bacterial; Quinolones; Randomized Controlled Trials as Topic | 2005 |
The role of carbapenems in the treatment of severe nosocomial respiratory tract infections.
Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cross Infection; Doripenem; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Ertapenem; Humans; Imipenem; Meropenem; Patient Selection; Pneumonia, Bacterial; Respiratory Tract Infections; Severity of Illness Index; Thienamycins; Treatment Outcome | 2008 |
Changing role of carbapenems in the treatment of lower respiratory tract infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ceftazidime; Cilastatin; Clinical Trials as Topic; Community-Acquired Infections; Cross Infection; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Meropenem; Middle Aged; Respiratory Tract Infections; Thienamycins | 1995 |
[Multicenter comparative study of meropenem vs. imipenem in the intramuscular treatment of hospital infections of the urinary tract].
Topics: Adult; Aged; Carbapenems; Chi-Square Distribution; Cilastatin; Cross Infection; Female; Humans; Imipenem; Male; Meropenem; Middle Aged; Protease Inhibitors; Thienamycins; Urinary Tract Infections | 1995 |
[The role of carbapenems in the treatment of nosocomial infection].
Topics: Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Cross Infection; Drug Therapy, Combination; Humans; Imipenem; Meningitis, Bacterial; Meropenem; Pneumonia, Bacterial; Skin Diseases, Infectious; Thienamycins | 1997 |
Imipenem.
Topics: Adolescent; Child; Child, Preschool; Cross Infection; Exanthema; Humans; Imipenem; Infant; Seizures; Thienamycins | 2001 |
Imipenem in acute lung infections and bacterial re-exacerbations of chronic obstructive lung disease.
Topics: Acute Disease; Cross Infection; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Pulmonary Disease, Chronic Obstructive; Respiratory Tract Infections; Thienamycins | 1991 |
Antimicrobial therapy of bacterial sepsis in the newborn infant.
Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Aztreonam; Bacteria; Cephalosporins; Cross Infection; Drug Therapy, Combination; Humans; Imipenem; Infant Mortality; Infant, Newborn; Penicillin Resistance; Penicillins; Sepsis; Thienamycins | 1985 |
28 trial(s) available for imipenem, anhydrous and Cross Infection
Article | Year |
---|---|
Population pharmacokinetics and pharmacodynamics of continuous versus short-term infusion of imipenem-cilastatin in critically ill patients in a randomized, controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Cilastatin; Critical Illness; Cross Infection; Drug Combinations; Female; Humans; Imipenem; Infusions, Intravenous; Logistic Models; Male; Middle Aged; Monte Carlo Method; Protease Inhibitors; Tandem Mass Spectrometry; Treatment Outcome | 2007 |
Activity of doripenem versus comparators in subjects with baseline bacteraemia in six pooled phase 3 clinical trials.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Cross Infection; Doripenem; Female; Humans; Imipenem; Intraabdominal Infections; Male; Meropenem; Ofloxacin; Pneumonia; Thienamycins; Treatment Outcome; Urinary Tract Infections | 2013 |
Pharmacokinetics of imipenem in critically ill patients during empirical treatment of nosocomial pneumonia: a comparison of 0.5-h and 3-h infusions.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Critical Illness; Cross Infection; Female; Humans; Imipenem; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Plasma; Pneumonia, Bacterial; Young Adult | 2014 |
A randomized open label study of 'imipenem vs. cefepime' in spontaneous bacterial peritonitis.
Topics: Adult; Anti-Bacterial Agents; Ascitic Fluid; Bacterial Infections; Cefepime; Cephalosporins; Cross Infection; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Imipenem; India; Liver Cirrhosis; Male; Middle Aged; Paracentesis; Peritonitis; Risk Factors; Severity of Illness Index; Survival Analysis; Time Factors | 2016 |
Comparison of tigecycline with imipenem/cilastatin for the treatment of hospital-acquired pneumonia.
Topics: Anti-Bacterial Agents; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Cross Infection; Double-Blind Method; Drug Combinations; Hospital Mortality; Humans; Imipenem; Microbial Sensitivity Tests; Minocycline; Pneumonia; Pneumonia, Ventilator-Associated; Tigecycline; Treatment Outcome | 2010 |
Early use of imipenem/cilastatin and vancomycin followed by de-escalation versus conventional antimicrobials without de-escalation for patients with hospital-acquired pneumonia in a medical ICU: a randomized clinical trial.
Topics: Aged; Anti-Infective Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Cross Infection; Drug Combinations; Female; Hospital Mortality; Humans; Imipenem; Intensive Care Units; Male; Middle Aged; Pneumonia, Bacterial; Time Factors; Treatment Outcome; Vancomycin | 2012 |
Levofloxacin compared with imipenem/cilastatin followed by ciprofloxacin in adult patients with nosocomial pneumonia: a multicenter, prospective, randomized, open-label study.
Topics: Adult; Aged; Anti-Bacterial Agents; Cilastatin; Ciprofloxacin; Cross Infection; Drug Therapy, Combination; Female; Humans; Imipenem; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia, Bacterial; Pneumonia, Staphylococcal; Prospective Studies; Pseudomonas aeruginosa | 2003 |
Early antibiotic treatment (prophylaxis) of septic complications in severe acute necrotizing pancreatitis: a prospective, randomized, multicenter study comparing two regimens with imipenem-cilastatin.
Topics: Aged; Antibiotic Prophylaxis; APACHE; Cause of Death; Cilastatin; Cilastatin, Imipenem Drug Combination; Cross Infection; Drug Administration Schedule; Drug Combinations; Female; Hospital Mortality; Humans; Imipenem; Incidence; Infection Control; Male; Middle Aged; Pancreatitis, Acute Necrotizing; Prospective Studies; Sepsis; Severity of Illness Index; Spain; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2003 |
Cefepime versus imipenem-cilastatin for treatment of nosocomial pneumonia in intensive care unit patients: a multicenter, evaluator-blind, prospective, randomized study.
Topics: Adult; Aged; APACHE; Cefepime; Cephalosporins; Cilastatin; Critical Care; Cross Infection; Double-Blind Method; Drug Therapy, Combination; Endpoint Determination; Female; Humans; Imipenem; Male; Middle Aged; Pneumonia, Pneumococcal; Prospective Studies; Protease Inhibitors; Respiration, Artificial; Thienamycins | 2003 |
Levofloxacin for treatment of ventilator-associated pneumonia: a subgroup analysis from a randomized trial.
Topics: Anti-Bacterial Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Cohort Studies; Cross Infection; Double-Blind Method; Drug Combinations; Drug Resistance, Bacterial; Female; Humans; Imipenem; Levofloxacin; Male; Middle Aged; Multivariate Analysis; Ofloxacin; Pneumonia, Bacterial; Prospective Studies; Thienamycins; Treatment Outcome; Ventilators, Mechanical | 2005 |
Comparison of piperacillin/tazobactam and imipenem/cilastatin, both in combination with tobramycin, administered every 6 h for treatment of nosocomial pneumonia.
Topics: Anti-Bacterial Agents; Cilastatin; Cross Infection; Double-Blind Method; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Imipenem; Male; Middle Aged; Penicillanic Acid; Piperacillin; Pneumonia, Ventilator-Associated; Protease Inhibitors; Tazobactam; Tobramycin; Treatment Outcome | 2006 |
Piperacillin/tazobactam vs imipenem/cilastatin in the treatment of nosocomial pneumonia--a double blind prospective multicentre study.
Topics: Adult; Cilastatin; Cross Infection; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Penicillanic Acid; Piperacillin; Pneumonia; Prospective Studies; Pseudomonas Infections; Tazobactam; Treatment Outcome | 2006 |
Prospective randomized comparison of imipenem monotherapy with imipenem plus netilmicin for treatment of severe infections in nonneutropenic patients.
Topics: Adult; Aged; Bacteremia; Bacterial Infections; Cross Infection; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Middle Aged; Netilmicin; Peritonitis; Pneumonia; Prospective Studies | 1994 |
Monotherapy in serious hospital-acquired infections: a clinical trial of ceftazidime versus imipenem/cilastatin. European Study Group.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria; Ceftazidime; Cilastatin; Cilastatin, Imipenem Drug Combination; Cross Infection; Drug Combinations; Female; Humans; Imipenem; Male; Middle Aged | 1993 |
[Comparative study of the cost-/effectiveness relationship of initial therapy with imipenem/cilastatin in nosocomial pneumonia. Group study].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cilastatin; Cost-Benefit Analysis; Critical Care; Cross Infection; Drug Therapy, Combination; Female; Humans; Imipenem; Length of Stay; Male; Middle Aged; Pneumonia, Bacterial; Protease Inhibitors; Thienamycins; Treatment Outcome | 1996 |
[Multicenter comparative study of meropenem vs. imipenem in the intramuscular treatment of hospital infections of the urinary tract].
Topics: Adult; Aged; Carbapenems; Chi-Square Distribution; Cilastatin; Cross Infection; Female; Humans; Imipenem; Male; Meropenem; Middle Aged; Protease Inhibitors; Thienamycins; Urinary Tract Infections | 1995 |
Treatment of pneumonia in mechanically ventilated trauma patients. Results of a prospective trial.
Topics: Aztreonam; Bronchoalveolar Lavage Fluid; Cilastatin; Cross Infection; Drug Therapy, Combination; HLA-DR Antigens; Humans; Imipenem; Pneumonia; Prospective Studies; Respiration, Artificial; Vancomycin; Wounds and Injuries | 1997 |
Prospective, randomised, multicentre study of meropenem versus imipenem/cilastatin as empiric monotherapy in severe nosocomial infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carbapenems; Cilastatin; Cilastatin, Imipenem Drug Combination; Cross Infection; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Meropenem; Middle Aged; Prospective Studies; Thienamycins | 1997 |
Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella.
Topics: Adult; Cephalosporin Resistance; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Drug Utilization Review; Guideline Adherence; Hospital Bed Capacity, 500 and over; Hospitals, Community; Humans; Imipenem; Incidence; Infection Control; Klebsiella; Klebsiella Infections; New York City; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins | 1998 |
Prospective randomized comparison of imipenem-cilastatin and piperacillin-tazobactam in nosocomial pneumonia or peritonitis.
Topics: Acute Disease; Adult; Aged; Cilastatin; Cilastatin, Imipenem Drug Combination; Cross Infection; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Middle Aged; Penicillanic Acid; Peritonitis; Piperacillin; Pneumonia; Prospective Studies; Pseudomonas Infections; Tazobactam | 1998 |
Clinical and economic evaluation of subsequent infection following intravenous ciprofloxacin or imipenem therapy in hospitalized patients with severe pneumonia.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Cost-Benefit Analysis; Cross Infection; Double-Blind Method; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Health Care Costs; Humans; Imipenem; Male; Patient Admission; Pneumonia, Bacterial; Prospective Studies; Retrospective Studies; Thienamycins | 1999 |
Treatment of severe nosocomial pneumonia: a prospective randomised comparison of intravenous ciprofloxacin with imipenem/cilastatin.
Topics: Adult; Aged; Anti-Infective Agents; Cilastatin; Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Female; Humans; Imipenem; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Protease Inhibitors; Survival Rate; Thienamycins; Treatment Outcome | 2000 |
Evaluation of endotoxin release and cytokine production induced by antibiotics in patients with Gram-negative nosocomial pneumonia.
Topics: Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Cross Infection; Cytokines; Female; Gram-Negative Bacterial Infections; Humans; Imipenem; Interleukin-1; Interleukin-6; Lipopolysaccharides; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Sepsis; Statistics, Nonparametric; Thienamycins; Tumor Necrosis Factor-alpha | 2002 |
Imipenem-cilastatin in the treatment of hospital infections.
Topics: Cilastatin; Cross Infection; Drug Therapy, Combination; Gram-Negative Bacterial Infections; Humans; Imipenem; Prognosis; Protease Inhibitors; Thienamycins; Treatment Outcome | 1991 |
Clinical and bacteriological efficacy, and practical aspects of amikacin given once daily for severe infections.
Topics: Adult; Aged; Amikacin; Bacterial Infections; Cefotaxime; Ceftazidime; Cross Infection; Drug Administration Schedule; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Male; Middle Aged; Ofloxacin; Piperacillin; Prospective Studies | 1991 |
Challenges in the design of trials to evaluate antibacterial agents in serious infections.
Topics: Ceftazidime; Cilastatin; Cross Infection; Drug Combinations; Europe; Female; Humans; Imipenem; Male; Multicenter Studies as Topic; Prospective Studies; Randomized Controlled Trials as Topic; Research Design; Urinary Tract Infections | 1990 |
Comparative clinical trial of ceftazidime and imipenem/cilastatin in patients with severe nosocomial pneumonias and septicaemias.
Topics: Ceftazidime; Cilastatin; Cross Infection; Drug Combinations; Female; Germany, West; Humans; Imipenem; Male; Middle Aged; Multicenter Studies as Topic; Pneumonia; Randomized Controlled Trials as Topic; Respiration, Artificial; Sepsis | 1990 |
Pefloxacin versus imipenem in the therapy of nosocomial lung infections of intensive care unit patients.
Topics: Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Cross Infection; Female; Humans; Imipenem; Injections, Intravenous; Intensive Care Units; Lung Diseases; Male; Middle Aged; Pefloxacin; Prospective Studies; Pseudomonas Infections; Time Factors | 1990 |
328 other study(ies) available for imipenem, anhydrous and Cross Infection
Article | Year |
---|---|
Detection of a new SHV-type extended-spectrum beta-lactamase, SHV-31, in a Klebsiella pneumoniae strain causing a large nosocomial outbreak in The Netherlands.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Humans; Intensive Care Units; Isoelectric Focusing; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Netherlands; Plasmids | 2007 |
In vitro activity of aurein 1.2 alone and in combination with antibiotics against gram-positive nosocomial cocci.
Topics: Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Cross Infection; Drug Synergism; Drug Therapy, Combination; Gram-Positive Cocci; Microbial Sensitivity Tests | 2007 |
Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Middle Aged; Portugal | 2007 |
Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Female; Humans; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Predictive Value of Tests; Proteus mirabilis; Risk Factors; Survival Analysis; Treatment Outcome | 2007 |
Spread in an Italian hospital of a clonal Acinetobacter baumannii strain producing the TEM-92 extended-spectrum beta-lactamase.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cross Infection; Humans; Italy; Microbial Sensitivity Tests | 2007 |
Enterobacteriaceae bloodstream infections: presence of integrons, risk factors, and outcome.
Topics: Bacteremia; Community-Acquired Infections; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae Infections; Gene Transfer, Horizontal; Humans; Infectious Disease Transmission, Professional-to-Patient; Integrons; Microbial Sensitivity Tests; Nucleic Acid Amplification Techniques; Polymerase Chain Reaction; Prospective Studies; Risk Factors; Sequence Analysis, DNA; Treatment Outcome | 2007 |
Characterization of an integron carrying blaIMP-1 and a new aminoglycoside resistance gene, aac(6')-31, and its dissemination among genetically unrelated clinical isolates in a Brazilian hospital.
Topics: Acinetobacter; Amino Acid Sequence; Aminoglycosides; Anti-Bacterial Agents; Base Sequence; Brazil; Codon, Terminator; Cross Infection; Drug Resistance, Multiple, Bacterial; Gene Transfer, Horizontal; Genes, Bacterial; Hospitals; Humans; Integrons; Microbial Sensitivity Tests; Molecular Sequence Data; Open Reading Frames; Plasmids; Pseudomonas putida; Transcription, Genetic | 2007 |
Molecular epidemiology of imipenem-resistant Acinetobacter haemolyticus and Acinetobacter baumannii isolates carrying plasmid-mediated OXA-40 from a Portuguese hospital.
Topics: Acinetobacter; Acinetobacter baumannii; Acinetobacter Infections; Bacterial Proteins; beta-Lactamases; Cross Infection; Humans; Plasmids; Portugal | 2007 |
Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals.
Topics: Acinetobacter; Acinetobacter Infections; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Blotting, Southern; Carbapenems; China; Chloramphenicol; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Hospitals; Humans; Imipenem; Integrons; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Sequence Data; Rifampin; Sequence Analysis, DNA | 2007 |
Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Chromosomes, Bacterial; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Integrons; Molecular Epidemiology; Molecular Sequence Data; Mutation; Plasmids; Polymerase Chain Reaction; Porins; Pseudomonas aeruginosa; Sequence Analysis, DNA; Sequence Homology, Amino Acid; Spain | 2007 |
Outbreak of Acinetobacter baumannii with chromosomally encoded VIM-1 undetectable by imipenem-EDTA synergy tests.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Chromosomes, Bacterial; Cross Infection; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Bacterial; Edetic Acid; Greece; Humans; Imipenem; Integrons; Isoelectric Focusing; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA | 2008 |
Carbapenem-resistant Acinetobacter baumannii isolates from Tunisia producing the OXA-58-like carbapenem-hydrolyzing oxacillinase OXA-97.
Topics: Acinetobacter baumannii; Africa; Bacterial Proteins; beta-Lactamases; Blotting, Southern; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Models, Genetic; Molecular Sequence Data; Polymerase Chain Reaction; Tunisia | 2008 |
Acquisition of a plasmid-borne blaOXA-58 gene with an upstream IS1008 insertion conferring a high level of carbapenem resistance to Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cross Infection; DNA Primers; DNA Transposable Elements; DNA, Bacterial; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Promoter Regions, Genetic; Transformation, Genetic | 2008 |
Metallo-beta-lactamase gene bla(IMP-15) in a class 1 integron, In95, from Pseudomonas aeruginosa clinical isolates from a hospital in Mexico.
Topics: Bacterial Proteins; beta-Lactamases; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Humans; Integrons; Mexico; Models, Genetic; Molecular Sequence Data; Pseudomonas aeruginosa; Pseudomonas Infections | 2008 |
Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Models, Genetic; Turkey | 2008 |
Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacteroides fragilis; Bacteroides Infections; Blood; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Taiwan | 2008 |
A plasmid-borne blaOXA-58 gene confers imipenem resistance to Acinetobacter baumannii isolates from a Lebanese hospital.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Conjugation, Genetic; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Hospitals, University; Humans; Imipenem; Lebanon; Molecular Epidemiology; Molecular Sequence Data; Plasmids | 2008 |
Genetic basis of multidrug resistance in Acinetobacter baumannii clinical isolates at a tertiary medical center in Pennsylvania.
Topics: Academic Medical Centers; Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Base Sequence; beta-Lactamases; Cross Infection; DNA Primers; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Pennsylvania; Polymerase Chain Reaction | 2008 |
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
Topics: Anti-Bacterial Agents; Base Sequence; beta-Lactamases; Colistin; Cross Infection; Humans; Molecular Sequence Data; Pseudomonas aeruginosa | 2009 |
Nonclonal emergence of colistin-resistant Klebsiella pneumoniae isolates from blood samples in South Korea.
Topics: Anti-Bacterial Agents; Bacteremia; Colistin; Cross Infection; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Population Surveillance; Republic of Korea | 2010 |
Phenotypic and genotypic characterization of Enterobacteriaceae with decreased susceptibility to carbapenems: results from large hospital-based surveillance studies in China.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactamases; Carbapenems; China; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae; Enterobacteriaceae Infections; Genotype; Integrons; Microbial Sensitivity Tests; Phenotype; Population Surveillance; Porins; Reverse Transcriptase Polymerase Chain Reaction | 2010 |
BEL-2, an extended-spectrum beta-lactamase with increased activity toward expanded-spectrum cephalosporins in Pseudomonas aeruginosa.
Topics: Belgium; beta-Lactamases; Cephalosporinase; Cephalosporins; Cross Infection; Escherichia coli; Genes, Bacterial; Humans; Kinetics; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections | 2010 |
In vitro potency of CXA-101, a novel cephalosporin, against Pseudomonas aeruginosa displaying various resistance phenotypes, including multidrug resistance.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Cephalosporins; Child; Child, Preschool; Cross Infection; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Infant; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Pseudomonas aeruginosa; Tazobactam; Young Adult | 2010 |
Activity of a new cephalosporin, CXA-101 (FR264205), against beta-lactam-resistant Pseudomonas aeruginosa mutants selected in vitro and after antipseudomonal treatment of intensive care unit patients.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Cephalosporins; Cross Infection; Humans; Intensive Care Units; Microbial Sensitivity Tests; Mutation; Pseudomonas aeruginosa; Pseudomonas Infections | 2010 |
OXA-24 carbapenemase gene flanked by XerC/XerD-like recombination sites in different plasmids from different Acinetobacter species isolated during a nosocomial outbreak.
Topics: Acinetobacter; Acinetobacter baumannii; Acinetobacter calcoaceticus; Acinetobacter Infections; Bacterial Proteins; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Cross Infection; Disease Outbreaks; DNA-Binding Proteins; Drug Resistance, Multiple, Bacterial; Gene Transfer, Horizontal; Genes, Bacterial; Humans; In Vitro Techniques; Molecular Epidemiology; Molecular Sequence Data; Plasmids; Recombination, Genetic; Spain; Species Specificity | 2010 |
Incidence and antimicrobial susceptibility of Escherichia coli and Klebsiella pneumoniae with extended-spectrum beta-lactamases in community- and hospital-associated intra-abdominal infections in Europe: results of the 2008 Study for Monitoring Antimicrob
Topics: Abdomen; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae | 2010 |
Detection of NDM-1-producing Klebsiella pneumoniae in Kenya.
Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Kenya; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Polymerase Chain Reaction | 2011 |
Factors behind the prevalence of carbapenem-resistant Klebsiella pneumoniae in pediatric wards.
Topics: Adult; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Child; Child, Preschool; China; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Imipenem; Infant; Infant, Newborn; Infection Control; Klebsiella Infections; Klebsiella pneumoniae; Male; Maternal-Child Health Services; Pregnancy | 2021 |
Molecular characterization of NDM-1-producing Pseudomonas aeruginosa isolates from hospitalized patients in Iran.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cross Infection; Drug Resistance, Multiple, Bacterial; Ertapenem; Humans; Imipenem; Inpatients; Iran; Microbial Sensitivity Tests; Molecular Typing; Polymerase Chain Reaction; Pseudomonas aeruginosa | 2021 |
Machine learning for identifying resistance features of
Topics: Amikacin; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Multiple, Bacterial; Genome, Bacterial; Gentamicins; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Machine Learning; Microbial Sensitivity Tests; Polymorphism, Single Nucleotide; Tetracyclines | 2021 |
Analysis of risk factors associated with healthcare-associated carbapenem-resistant Klebsiella pneumoniae infection in a large general hospital: a case-case-control study.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Case-Control Studies; Cross Infection; Delivery of Health Care; Drug Resistance, Bacterial; Hospitals, General; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Risk Factors | 2023 |
An insight into analysis and elimination of plasmids encoding metallo-β-lactamases in Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamases; Cefotaxime; Cross Infection; DNA Copy Number Variations; Drug Resistance, Multiple, Bacterial; Ertapenem; Gene Expression Regulation, Bacterial; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Plasmids; Pseudomonas aeruginosa; Pseudomonas Infections; Sodium Dodecyl Sulfate; Suppuration; Urine | 2020 |
Phenotypic and genotypic detection of metallo-β-lactamases in A. baumanii isolates obtained from clinical samples in Shahrekord, southwest Iran.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cross Infection; Drug Resistance, Multiple, Bacterial; Genotype; Imipenem; Iran; Meropenem; Metalloproteins; Microbial Sensitivity Tests; Phenotype | 2019 |
Multidrug-resistant Klebsiella pneumoniae in hospital-acquired infections: Concomitant analysis of antimicrobial resistant strains.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Child; Ciprofloxacin; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Genotype; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Phenotype; Young Adult | 2020 |
Molecular detection and antibiotic resistance pattern of extended-spectrum beta-lactamase producing Escherichia coli in a Tertiary Hospital in Enugu, Nigeria.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Cross Infection; Cross-Sectional Studies; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Genes, Bacterial; Humans; Imipenem; Male; Middle Aged; Nigeria; Risk Factors; Tertiary Care Centers; Young Adult | 2019 |
An investigation of Stenotrophomonas maltophilia-positive culture caused by fiberoptic bronchoscope contamination.
Topics: Anti-Bacterial Agents; Bronchoscopes; Ceftazidime; Cross Infection; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacterial Infections; Humans; Imipenem; Microbial Sensitivity Tests; Stenotrophomonas maltophilia | 2019 |
Dissemination of carbapenem-resistant Pseudomonas aeruginosa isolates and their susceptibilities to ceftolozane-tazobactam in Germany.
Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Germany; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam | 2020 |
Adaptations of carbapenem resistant
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adaptation, Physiological; Adult; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Biofilms; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Environmental Microbiology; Female; Genes, Bacterial; Humans; Imipenem; Integrons; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Risk Factors; Virulence | 2021 |
Multilocus sequence typing and molecular characterization of β-lactamase genes among Acinetobacter baumannii isolates in a burn center.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Burn Units; Burns; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Meropenem; Molecular Epidemiology; Multilocus Sequence Typing; Thienamycins; Wound Infection | 2017 |
Outbreak of imipenem-resistant Acinetobacter baumannii in different wards at a regional hospital related to untrained bedside caregivers.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Attitude of Health Personnel; beta-Lactam Resistance; Caregivers; Cross Infection; Disease Outbreaks; Electrophoresis, Gel, Pulsed-Field; Female; Guideline Adherence; Hand Hygiene; Health Knowledge, Attitudes, Practice; Hospitals, General; Humans; Imipenem; Infection Control; Male; Middle Aged; Molecular Typing; Taiwan; Young Adult | 2017 |
Bacteremia caused by Elizabethkingia meningoseptica in a mechanically ventilated patient successfully treated with imipenem-cilastatin and ciprofloxacin.
Topics: Anti-Bacterial Agents; Bacteremia; Cilastatin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Cross Infection; Drug Combinations; Drug Resistance, Multiple, Bacterial; Flavobacteriaceae Infections; Humans; Imipenem; Male; Middle Aged | 2017 |
Clinical Outcome and Antimicrobial Therapeutic Drug Monitoring for the Treatment of Infections in Acute Burn Patients.
Topics: Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Burns; Child; Child, Preschool; Cross Infection; Drug Monitoring; Female; Humans; Imipenem; Infant; Intensive Care Units; Male; Meropenem; Middle Aged; Piperacillin; Pneumonia; Prognosis; Tertiary Care Centers; Thienamycins; Urinary Tract Infections; Vancomycin; Young Adult | 2017 |
Update of incidence and antimicrobial susceptibility trends of Escherichia coli and Klebsiella pneumoniae isolates from Chinese intra-abdominal infection patients.
Topics: Abdomen; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; China; Community-Acquired Infections; Cross Infection; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Incidence; Intraabdominal Infections; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2017 |
Prevalence of class 1 integrons and plasmid-mediated qnr-genes among Enterobacter isolates obtained from hospitalized patients in Ahvaz, Iran.
Topics: Anti-Bacterial Agents; Cross Infection; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Enterobacter; Enterobacteriaceae Infections; Fluoroquinolones; Genes, Bacterial; Humans; Imipenem; Integrons; Iran; Meropenem; Microbial Sensitivity Tests; Plasmids; Thienamycins | 2017 |
Colistin-resistant carbapenemase-producing isolates among Klebsiella spp. and Acinetobacter baumannii in Tripoli, Libya.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Colistin; Cross Infection; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Health Facilities; Humans; Imipenem; Klebsiella; Libya; Microbial Sensitivity Tests; Multilocus Sequence Typing | 2018 |
Impact of intensive care unit relocation and role of tap water on an outbreak of Pseudomonas aeruginosa expressing OprD-mediated resistance to imipenem.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Cross Infection; Disease Outbreaks; Drinking Water; Electrophoresis, Gel, Pulsed-Field; Female; Genotype; Humans; Imipenem; Infection Control; Intensive Care Units; Male; Middle Aged; Molecular Epidemiology; Molecular Typing; Porins; Pseudomonas aeruginosa; Pseudomonas Infections | 2018 |
[Analysis of the distribution characteristics and drug resistance of non-fermenting bacterial infection in intensive care unit from 2009 to 2015]
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Infections; Cefepime; Cefoperazone; Cephalosporins; Cross Infection; Drug Resistance; Drug Resistance, Bacterial; Gram-Negative Bacteria; Humans; Imipenem; Intensive Care Units; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Retrospective Studies; Thienamycins | 2016 |
Weather, climate control, and imipenem-resistance in Acinetobacter baumannii: an ecological approach.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Brazil; Climate; Cross Infection; Drug Resistance, Bacterial; Hospital Units; Humans; Imipenem; Microbial Sensitivity Tests; Temperature; Weather | 2018 |
A prospective multicenter study on the evaluation of antimicrobial resistance and molecular epidemiology of multidrug-resistant Acinetobacter baumannii infections in intensive care units with clinical and environmental features.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Colistin; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Imipenem; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Phylogeny; Prospective Studies; Turkey | 2019 |
Antibiotics with activity against intestinal anaerobes and the hazard of acquired colonization with ceftriaxone-resistant Gram-negative pathogens in ICU patients: a propensity score-based analysis.
Topics: Aged; Anti-Bacterial Agents; Bacteria, Anaerobic; Carbapenems; Ceftriaxone; Cross Infection; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Intensive Care Units; Intestines; Male; Meropenem; Middle Aged; Propensity Score; Retrospective Studies | 2019 |
Repeated colonization by multi-drug-resistant Acinetobacter calcoaceticus-A. baumannii complex and changes in antimicrobial susceptibilities in surgical intensive care units.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Cefepime; Cephalosporins; Chi-Square Distribution; China; Cilastatin; Cilastatin, Imipenem Drug Combination; Critical Care; Cross Infection; Disease Outbreaks; Drug Combinations; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Imipenem; Microbial Sensitivity Tests; Public Health Surveillance; Retrospective Studies | 2013 |
Clinical outcomes of tigecycline alone or in combination with other antimicrobial agents for the treatment of patients with healthcare-associated multidrug-resistant Acinetobacter baumannii infections.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; Ceftazidime; Ceftriaxone; Cilastatin; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Minocycline; Piperacillin; Sulbactam; Tigecycline; Treatment Outcome | 2013 |
Impact of ertapenem use on Pseudomonas aeruginosa and Acinetobacter baumannii imipenem susceptibility rates: collateral damage or positive effect on hospital ecology?
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Ciprofloxacin; Cross Infection; Drug Utilization; Ecosystem; Ertapenem; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Retrospective Studies; Selection, Genetic; Tertiary Care Centers | 2013 |
Risk factors for imipenem-nonsusceptible Acinetobacter nosocomialis bloodstream infection.
Topics: Academic Medical Centers; Acinetobacter; Acinetobacter Infections; Aged; Aged, 80 and over; Bacteremia; beta-Lactam Resistance; Cross Infection; Female; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Odds Ratio; Retrospective Studies; Risk Factors | 2014 |
A 10 year surveillance for antimicrobial susceptibility of Escherichia coli and Klebsiella pneumoniae in community- and hospital-associated intra-abdominal infections in China.
Topics: Anti-Bacterial Agents; beta-Lactams; China; Community-Acquired Infections; Cross Infection; Ertapenem; Escherichia coli; Humans; Imipenem; Intraabdominal Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Prevalence | 2013 |
Prevalence and molecular epidemiology of imipenem-resistant Pseudomonas aeruginosa carrying metallo-beta-lactamases from two central hospitals in Portugal.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cross Infection; Gene Transfer, Horizontal; Hospitals, Urban; Humans; Imipenem; Integrons; Microbial Sensitivity Tests; Molecular Epidemiology; Portugal; Prevalence; Pseudomonas aeruginosa; Pseudomonas Infections | 2013 |
Nosocomial infection by sequence type 357 multidrug-resistant Acinetobacter baumannii isolates in a neonatal intensive care unit in Daejeon, Korea.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Infant, Newborn; Intensive Care Units, Neonatal; Microbial Sensitivity Tests; Multilocus Sequence Typing; Multiplex Polymerase Chain Reaction; Republic of Korea | 2013 |
Carbapenem resistance in Acinetobacter baumannii: where is it heading?
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cross Infection; Hospitals, University; Humans; Imipenem; Intensive Care Units; Meropenem; Microbial Sensitivity Tests; Prognosis; Risk Factors; Thienamycins; Turkey | 2013 |
[Analysis of drug resistance and drug resistance genes of imipenem-resistant Pseudomonas aeruginosa strains isolated from burn wards].
Topics: Burns; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 2014 |
Which proportion of extended-spectrum beta-lactamase producing strains could be treated by non-carbapenem beta-lactams?
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; France; Humans; Imipenem; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Substrate Specificity | 2014 |
[In vitro synergistic activity of sulbactam in combination with imipenem, meropenem and cefoperazone against carbapenem-resistant Acinetobacter baumannii isolates].
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cefoperazone; Cross Infection; Drug Combinations; Drug Synergism; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Sulbactam; Thienamycins | 2014 |
Clinical outcomes of hospital-acquired infection with Acinetobacter nosocomialis and Acinetobacter pittii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Animals; Anti-Bacterial Agents; Cohort Studies; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Imipenem; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Moths; Retrospective Studies; Thienamycins; Treatment Outcome | 2014 |
Changes in causative pathogens of acute cholangitis and their antimicrobial susceptibility over a period of 6 years.
Topics: Acute Disease; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Cholangitis; Citrobacter freundii; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Female; Humans; Imipenem; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Time Factors | 2014 |
Risk factors for the acquisition of imipenem-resistant Acinetobacter baumannii in a burn unit: An appraisal of the effect of colonization pressure.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; Burn Units; Cohort Studies; Cross Infection; Female; Humans; Imipenem; Male; Middle Aged; Retrospective Studies; Risk Factors | 2014 |
Multidrug and extensive drug resistance in Pseudomonas aeruginosa clinical isolates from a Portuguese central hospital: 10-year survey.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Gentamicins; Hospitals; Humans; Imipenem; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Young Adult | 2015 |
Description of the OXA-23 β-lactamase gene located within Tn2007 in a clinical isolate of Acinetobacter baumannii from Spain.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; DNA Transposable Elements; Drug Resistance, Bacterial; Humans; Imipenem; Male; Microbial Sensitivity Tests; Spain | 2015 |
Molecular mechanisms associated with nosocomial carbapenem-resistant Acinetobacter baumannii in Mexico.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Biological Transport; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Hospitals; Humans; Hydrazones; Imipenem; Meropenem; Mexico; Microbial Sensitivity Tests; Thienamycins | 2014 |
Successful containment of carbapenem-resistant Enterobacteriaceae by strict contact precautions without active surveillance.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Containment of Biohazards; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals, Teaching; Humans; Imipenem; Incidence; Infection Control; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Phenotype; Prevalence; Prospective Studies; Republic of Korea; Retrospective Studies; Thienamycins | 2014 |
Increasing resistance of nosocomial Acinetobacter baumannii: are we going to be defeated?
Topics: Acinetobacter baumannii; Cross Infection; Drug Resistance, Bacterial; Imipenem; Intensive Care Units; Meropenem; Microbial Sensitivity Tests; Thienamycins; Time Factors | 2014 |
Alveolar and serum concentrations of imipenem in two lung transplant recipients supported with extracorporeal membrane oxygenation.
Topics: Anti-Bacterial Agents; Creatinine; Cross Infection; Extracorporeal Membrane Oxygenation; Humans; Imipenem; Lung Transplantation; Male; Middle Aged; Respiratory Distress Syndrome; Respiratory Insufficiency; Transplant Recipients | 2015 |
Emergence of Colistin- and Carbapenem-Resistant Acinetobacter baumannii ST2 Clinical Isolate in Algeria: First Case Report.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Algeria; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactamases; Clone Cells; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Edetic Acid; Female; Gene Expression Regulation, Bacterial; Humans; Imipenem; Male; Microbial Sensitivity Tests; Molecular Sequence Data; Multilocus Sequence Typing; Mutation; Phylogeny; Plasmids; Sequence Alignment; Sequence Analysis, DNA; Transcription Factors | 2015 |
Identification and characteristics of imipenem-resistant Acinetobacter baumannii in surgical wards in a Chinese university hospital.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacterial Proteins; beta-Lactamases; China; Colistin; Cross Infection; Drug Resistance, Multiple; Drug Resistance, Multiple, Bacterial; Hospital Units; Hospitals, University; Humans; Imipenem; Intensive Care Units; Microbial Sensitivity Tests; Molecular Typing | 2015 |
A novel New Delhi metallo-β-lactamase variant, NDM-14, isolated in a Chinese Hospital possesses increased enzymatic activity against carbapenems.
Topics: Acinetobacter; Acinetobacter Infections; Amino Acid Substitution; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; China; Cross Infection; Drug Resistance, Bacterial; Humans; Imipenem; Intensive Care Units; Kinetics; Meropenem; Molecular Sequence Data; Plasmids; Thienamycins | 2015 |
A gloves-associated outbreak of imipenem-resistant Acinetobacter baumannii in an intensive care unit in Guangdong, China.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Case-Control Studies; China; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Equipment Contamination; Female; Gloves, Protective; Humans; Imipenem; Infection Control; Intensive Care Units; Male; Middle Aged | 2015 |
Spread of OXA-23-producing Acinetobacter baumannii ST2 and ST246 in a hospital in Japan.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Cross Infection; Drug Resistance, Multiple, Bacterial; Hospitals; Humans; Imipenem; Japan; Meropenem; Microbial Sensitivity Tests; Multilocus Sequence Typing; Thienamycins | 2015 |
Emergence in Taiwan of novel imipenem-resistant Acinetobacter baumannii ST455 causing bloodstream infection in critical patients.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; Bacteremia; Cross Infection; DNA, Intergenic; Drug Resistance, Bacterial; Female; Humans; Imipenem; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Taiwan | 2015 |
Can Plazomicin Alone or in Combination Be a Therapeutic Option against Carbapenem-Resistant Acinetobacter baumannii?
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; beta-Lactam Resistance; Cross Infection; Drug Synergism; Drug Therapy, Combination; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Sisomicin; Thienamycins | 2015 |
Risk factors and clinical significance of bacteremia caused by Pseudomonas aeruginosa resistant only to carbapenems.
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Blood Culture; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Case-Control Studies; Cephalosporins; Ciprofloxacin; Cross Infection; Female; Hospitals; Humans; Imipenem; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Mortality; Multivariate Analysis; Odds Ratio; Penicillins; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Risk Factors; Severity of Illness Index; Taiwan; Thienamycins | 2017 |
Antimicrobial Susceptibilities of Aerobic and Facultative Gram-Negative Bacilli from Intra-abdominal Infections in Patients from Seven Regions in China in 2012 and 2013.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefoxitin; China; Ciprofloxacin; Community-Acquired Infections; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Gene Expression; Humans; Imipenem; Intraabdominal Infections; Levofloxacin; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam | 2016 |
Comparative Phosphoproteomics Reveals the Role of AmpC β-lactamase Phosphorylation in the Clinical Imipenem-resistant Strain Acinetobacter baumannii SK17.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Binding Sites; Cross Infection; Humans; Imipenem; Models, Molecular; Mutation; Phosphoproteins; Phosphorylation; Protein Structure, Tertiary; Proteome; Proteomics; Tandem Mass Spectrometry | 2016 |
EMERGENCY ROOM: AN UNRECOGNIZED SOURCE OF EXTENDED-SPECTRUM β-LACTAMASE PRODUCING ESCHERICHIA COLI AND KLEBSIELLA PNEUMONIAE.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cross Infection; Emergency Service, Hospital; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Middle Aged; Plasmids; Thailand; Thienamycins; Young Adult | 2015 |
Nosocomial Acinetobacter pneumonia: Treatment and prognostic factors in 356 cases.
Topics: Acinetobacter baumannii; Acinetobacter calcoaceticus; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Imipenem; Male; Middle Aged; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Prognosis; Retrospective Studies; Risk Factors; Severity of Illness Index; Shock, Septic | 2016 |
Epidemiology and Antimicrobial Susceptibility of Gram-Negative Pathogens Causing Intra-abdominal Infections in Pediatric Patients in Europe-SMART 2011-2014.
Topics: Adolescent; Amikacin; Appendicitis; Child; Child, Preschool; Community-Acquired Infections; Cross Infection; Cross-Sectional Studies; Drug Resistance, Microbial; Drug Resistance, Multiple, Bacterial; Europe; Female; Gram-Negative Bacterial Infections; Humans; Imipenem; Infant; Male; Microbial Sensitivity Tests | 2017 |
OXA-Carbapenemases Present in Clinical Acinetobacter baumannii-calcoaceticus Complex Isolates from Patients in Kurdistan Region, Iraq.
Topics: Acinetobacter baumannii; Acinetobacter calcoaceticus; Acinetobacter Infections; Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Child; Child, Preschool; Clone Cells; Cross Infection; Disk Diffusion Antimicrobial Tests; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Gene Expression Regulation, Bacterial; Humans; Imipenem; Iraq; Male; Middle Aged; Multilocus Sequence Typing; Phylogeny; Plasmids; Polymerase Chain Reaction; Prevalence | 2016 |
Comparative in vitro activity of carbapenems against clinical isolates of Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cross Infection; Doripenem; Humans; Imipenem; Iran; Meropenem; Microbial Sensitivity Tests; Thienamycins | 2016 |
Emergence and interhospital spread of OXA-48-producing Klebsiella pneumoniae ST395 clone in Western Hungary.
Topics: beta-Lactamases; Cross Infection; Genotype; Hospitals; Humans; Hungary; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Molecular Typing; Thienamycins | 2017 |
Rapid increase in resistance to third generation cephalosporins, imipenem and co-resistance in Klebsiella pneumoniae from isolated from 7,140 blood-cultures (2010-2014) using EARS-Net data in Spain.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Catchment Area, Health; Cephalosporins; Child; Child, Preschool; Ciprofloxacin; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Imipenem; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Population Surveillance; Spain; Young Adult | 2017 |
Antibiotic Treatment of Hospitalized Patients with Pneumonia Complicated by Clostridium Difficile Infection.
Topics: Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Ceftriaxone; Cefuroxime; Ciprofloxacin; Clarithromycin; Clavulanic Acid; Clostridioides difficile; Clostridium Infections; Cross Infection; Female; Hospitalization; Host-Pathogen Interactions; Humans; Imipenem; Male; Pneumonia; Retrospective Studies; Treatment Outcome | 2016 |
Detection of Escherichia coli ST131 clonal complex (ST705) and Klebsiella pneumoniae ST15 among faecal carriage of extended-spectrum β-lactamase- and carbapenemase-producing Enterobacteriaceae.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Proteins; beta-Lactamases; Carrier State; Cefotaxime; Ceftazidime; Child; Child, Preschool; Cross Infection; Culture Media; Drug Resistance, Multiple, Bacterial; Escherichia coli; Feces; Female; Gastrointestinal Microbiome; Hospitalization; Humans; Imipenem; Infant; Intestines; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Spain; Thienamycins; Young Adult | 2017 |
Molecular epidemiology of bla
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactamases; Carbapenems; China; Cross Infection; Drug Resistance, Multiple, Bacterial; Follow-Up Studies; Humans; Imipenem; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing | 2017 |
Emergence of Imipenem-Resistant Pseudomonas aeruginosa Clinical Isolates from Egypt Coharboring VIM and IMP Carbapenemases.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Egypt; Humans; Imipenem; Inosine Monophosphate; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections | 2017 |
Epidemiology and susceptibility of pathogens from SMART 2011-12 Turkey: evaluation of hospital-acquired versus community-acquired urinary tract infections and ICU- versus non-ICU-associated intra-abdominal infections.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cefoxitin; Community-Acquired Infections; Cross Infection; Enterobacteriaceae; Ertapenem; Escherichia coli; Humans; Imipenem; Intensive Care Units; Intraabdominal Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Turkey; Urinary Tract Infections | 2017 |
Hospital-acquired pneumonia due to Achromobacter xylosoxidans in the elderly: A single-center retrospective study in Beijing.
Topics: Achromobacter denitrificans; Aged; Aged, 80 and over; Anti-Bacterial Agents; Beijing; beta-Lactam Resistance; Catheters, Indwelling; Cross Infection; Female; Gram-Negative Bacterial Infections; Hospitals, General; Hospitals, Veterans; Humans; Imipenem; Male; Pneumonia, Bacterial; Retrospective Studies; Risk Factors | 2017 |
Is continuous infusion of imipenem always the best choice?
Topics: Aged; Anti-Bacterial Agents; Critical Illness; Cross Infection; Female; Gram-Negative Bacteria; Humans; Imipenem; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Plasma; Pneumonia, Bacterial; Staphylococcus aureus; Time Factors | 2017 |
Molecular epidemiology and antimicrobial resistance phenotypes of Acinetobacter baumannii isolated from patients in three hospitals in southern Vietnam.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cluster Analysis; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Hospitals; Humans; Imipenem; Longitudinal Studies; Male; Middle Aged; Molecular Epidemiology; Multilocus Sequence Typing; Phenotype; Prevalence; Tandem Repeat Sequences; Vietnam; Young Adult | 2017 |
Epidemiology of metalloenzyme-producing Pseudomonas aeruginosa in a tertiary hospital in Greece.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; Case-Control Studies; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Genome, Bacterial; Greece; Humans; Imipenem; Phylogeny; Pseudomonas aeruginosa; Pseudomonas Infections | 2008 |
Antimicrobial susceptibility and molecular epidemiological analysis of clinical strains of Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; beta-Lactamases; Blood; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Hospitals, University; Humans; Imipenem; Japan; Microbial Sensitivity Tests; Molecular Epidemiology; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory System; Urine | 2008 |
Association between antibiotic usage and subsequent colonization or infection of extensive drug-resistant Acinetobacter baumannii: a matched case-control study in intensive care units.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Case-Control Studies; Ceftazidime; Chi-Square Distribution; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Imipenem; Intensive Care Units; Male; Meropenem; Middle Aged; Regression Analysis; Thienamycins | 2008 |
[Presence of metallo beta-lactamases in imipenem-resistant Pseudomonas aeruginosa].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Child; Child, Preschool; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Genes, Bacterial; Humans; Imipenem; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Middle Aged; Polymerase Chain Reaction; Pseudomonas aeruginosa; Pseudomonas Infections; Young Adult | 2008 |
Molecular characterisation of the metallo-beta-lactamase genes in imipenem-resistant Gram-negative bacteria from a university hospital in southern Taiwan.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cross Infection; DNA, Bacterial; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals, University; Humans; Hybridization, Genetic; Imipenem; Integrons; Microbial Sensitivity Tests; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; Taiwan | 2008 |
Nosocomial colonization due to imipenem-resistant Pseudomonas aeruginosa epidemiologically linked to breast milk feeding in a neonatal intensive care unit.
Topics: Anti-Bacterial Agents; Breast Feeding; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Imipenem; Infant, Newborn; Intensive Care Units, Neonatal; Male; Microbial Sensitivity Tests; Milk, Human; Proportional Hazards Models; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Survival Rate | 2008 |
Imipenem-resistant Pseudomonas aeruginosa: risk factors for nosocomial infections.
Topics: Adult; Aged; Anti-Bacterial Agents; Case-Control Studies; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Imipenem; Length of Stay; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Vancomycin | 2008 |
[Surveillance of multidrug resistant bacteria in a Tunisian hospital].
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Infections; Burns; Ceftazidime; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Enterobacteriaceae; Hospitals, Urban; Humans; Imipenem; Microbial Sensitivity Tests; Practice Guidelines as Topic; Pseudomonas aeruginosa; Retrospective Studies; Sentinel Surveillance; Staphylococcus aureus; Tunisia | 2008 |
Surveillance of intrahospital infections at the clinic for gynaecology and obstetrics.
Topics: Anti-Bacterial Agents; Bosnia and Herzegovina; Cefepime; Cephalosporins; Cross Infection; Female; Humans; Imipenem; Klebsiella pneumoniae; Obstetrics and Gynecology Department, Hospital; Population Surveillance; Prevalence; Prospective Studies; Proteus mirabilis; Pseudomonas aeruginosa; Staphylococcus aureus; Streptococcus; Surgical Wound Infection; Urinary Tract Infections; Vancomycin | 2009 |
Clinical impact of imipenem-resistant Pseudomonas aeruginosa bloodstream infections.
Topics: Adult; Aged; Analysis of Variance; Bacteremia; Cross Infection; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Hospitals, Teaching; Humans; Imipenem; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies | 2009 |
Attributable mortality of imipenem-resistant nosocomial Acinetobacter baumannii bloodstream infection.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Cohort Studies; Confounding Factors, Epidemiologic; Cross Infection; Drug Resistance, Bacterial; Female; Hospital Bed Capacity, 500 and over; Hospital Mortality; Humans; Imipenem; Length of Stay; Male; Middle Aged; Multivariate Analysis; Prognosis; Proportional Hazards Models; Retrospective Studies; Survival Rate; Thailand | 2009 |
The impact of ertapenem use on the susceptibility of Pseudomonas aeruginosa to imipenem: a hospital case study.
Topics: Academic Medical Centers; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Brazil; Cross Infection; Drug Resistance, Bacterial; Drug Utilization; Ertapenem; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections | 2009 |
Nosocomial outbreak by imipenem-resistant metallo-beta-lactamase-producing Pseudomonas aeruginosa in an adult intensive care unit in a Brazilian teaching hospital.
Topics: beta-Lactamases; Brazil; Case-Control Studies; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Female; Hospitals, Teaching; Humans; Imipenem; Intensive Care Units; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections | 2009 |
Epidemiology of antimicrobial resistance among gram-negative organisms recovered from patients in a multistate network of long-term care facilities.
Topics: Anti-Bacterial Agents; Ceftazidime; Colony Count, Microbial; Cross Infection; Cross-Sectional Studies; Delaware; Drug Resistance, Bacterial; Escherichia coli; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Imipenem; Klebsiella; Long-Term Care; Microbial Sensitivity Tests; New Jersey; Pennsylvania; Prevalence; Proteus mirabilis; Skilled Nursing Facilities | 2009 |
Mixture model to assess the extent of cross-transmission of multidrug-resistant pathogens in hospitals.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Infections; Cross Infection; Disease Reservoirs; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Infection Control; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Poisson Distribution; Probability; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Time Factors | 2009 |
Characterization of multidrug-resistant and extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strains from Malaysian hospitals.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Conjugation, Genetic; Cross Infection; DNA Fingerprinting; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Hospitals, Public; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Malaysia; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction | 2009 |
Efficacy of intravenous infusion of doripenem.
Topics: Carbapenems; Cross Infection; Doripenem; Humans; Imipenem; Infusions, Intravenous; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Ventilator-Associated | 2009 |
Clinical and economic consequences of ventilator-associated pneumonia.
Topics: Anti-Bacterial Agents; Carbapenems; Cross Infection; Doripenem; Health Care Costs; Hospital Mortality; Humans; Imipenem; Intensive Care Units; Length of Stay; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Severity of Illness Index | 2009 |
The role of patient-to-patient transmission in the acquisition of imipenem-resistant Pseudomonas aeruginosa colonization in the intensive care unit.
Topics: Adult; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Imipenem; Intensive Care Units; Pseudomonas aeruginosa; Pseudomonas Infections | 2009 |
Accuracy of American Thoracic Society/Infectious Diseases Society of America criteria in predicting infection or colonization with multidrug-resistant bacteria at intensive-care unit admission.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamases; Causality; Ceftazidime; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Infection Control; Intensive Care Units; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Patient Admission; Pneumonia, Bacterial; Practice Guidelines as Topic; Prospective Studies; Pseudomonas aeruginosa; Risk Factors; Societies, Medical; Stenotrophomonas maltophilia | 2010 |
Polyclonal spread of bla(OXA-23) and bla(OXA-58) in Acinetobacter baumannii isolates from Argentina.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Argentina; beta-Lactamases; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Humans; Imipenem; Meropenem; Polymerase Chain Reaction; Sequence Analysis, DNA; Thienamycins | 2008 |
First isolation of a VIM-producing Klebsiella pneumoniae from a seven-year-old child in Venezuela.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactam Resistance; beta-Lactamases; Cefepime; Cephalosporins; Child; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Quinolones; Thienamycins; Urine; Venezuela | 2008 |
Imipenem-resistant Pseudomonas aeruginosa gastrointestinal carriage among hospitalized patients: risk factors and resistance mechanisms.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; Carrier State; Cohort Studies; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Imipenem; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Porins; Prospective Studies; Pseudomonas aeruginosa; Rectum; Risk Factors | 2010 |
[Influence of antibiotic-therapy on the selection of multi-drug resistant pathogens].
Topics: Amoxicillin-Potassium Clavulanate Combination; Ceftazidime; Cross Infection; Drug Resistance, Multiple; Humans; Imipenem; Methicillin-Resistant Staphylococcus aureus | 2009 |
Distribution of different carbapenem resistant clones of Acinetobacter baumannii in Tehran hospitals.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cefotaxime; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Hospitals; Humans; Imipenem; Iran; Meropenem; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Thienamycins | 2009 |
Epidemiology and impact of imipenem resistance in Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; Case-Control Studies; Cohort Studies; Costs and Cost Analysis; Cross Infection; Female; Humans; Imipenem; Length of Stay; Male; Middle Aged; Multivariate Analysis; Pennsylvania; Prevalence; Risk Factors | 2009 |
[Evolution of Enterobacteriaceae resistance to antibiotics in Reunion Island: emergence of extended-spectrum beta-lactamases].
Topics: Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Cephalosporin Resistance; Cephalosporinase; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Utilization; Enterobacteriaceae; Enterobacteriaceae Infections; Fluoroquinolones; Humans; Imipenem; Retrospective Studies; Reunion; Substrate Specificity | 2010 |
Growth in glucose-based medium and exposure to subinhibitory concentrations of imipenem induce biofilm formation in a multidrug-resistant clinical isolate of Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Adhesion; Biofilms; Cross Infection; Culture Media; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Gene Expression Profiling; Glucose; Humans; Imipenem; Iron; Polysaccharides, Bacterial | 2009 |
Mechanisms of resistance to ciprofloxacin, ampicillin/sulbactam and imipenem in Acinetobacter baumannii clinical isolates in Taiwan.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Cross Infection; DNA, Bacterial; Drug Resistance, Bacterial; Gene Expression; Humans; Imipenem; Integrons; Point Mutation; Polymerase Chain Reaction; Sequence Analysis, DNA; Sulbactam; Taiwan | 2010 |
Therapeutic equivalence of generic imipenem/cilastatin for therapy of infections at Siriraj Hospital.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Cilastatin; Cross Infection; Drugs, Generic; Female; Hospitalization; Hospitals, University; Humans; Imipenem; Male; Medical Records; Middle Aged; Thailand; Therapeutic Equivalency; Treatment Outcome | 2010 |
Nosocomial imipenem-resistant Acinetobacter baumannii infections: epidemiology and risk factors.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Imipenem; Incidence; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial; Respiration, Artificial; Risk Factors | 2010 |
The ongoing challenge of acquired carbapenemases: a hospital outbreak of Klebsiella pneumoniae simultaneously producing VIM-1 and KPC-2.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cross Infection; Disease Outbreaks; Greece; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Thienamycins | 2010 |
Outbreak of Acinetobacter baumannii producing OXA-66 in a Spanish hospital: epidemiology and study of patient movements.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Hospitals, Urban; Humans; Imipenem; Microbial Sensitivity Tests; Patient Transfer; Random Amplified Polymorphic DNA Technique; Spain | 2010 |
Patients with Acinetobacter baumannii bloodstream infections are colonized in the gastrointestinal tract with identical strains.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Bacterial Typing Techniques; beta-Lactam Resistance; Blood; Critical Illness; Cross Infection; DNA Fingerprinting; Electrophoresis, Gel, Pulsed-Field; Female; Gastrointestinal Tract; Humans; Imipenem; Male; Middle Aged; Molecular Epidemiology | 2010 |
Increase of ceftazidime- and fluoroquinolone-resistant Klebsiella pneumoniae and imipenem-resistant Acinetobacter spp. in Korea: analysis of KONSAR study data from 2005 and 2007.
Topics: Acinetobacter; Bacterial Infections; Ceftazidime; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Fluoroquinolones; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Methicillin-Resistant Staphylococcus aureus; Pseudomonas aeruginosa; Republic of Korea; Vancomycin | 2010 |
Extended measures for controlling an outbreak of VIM-1 producing imipenem-resistant Klebsiella pneumoniae in a liver transplant centre in France, 2003-2004.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Female; France; Hospital Bed Capacity, 500 and over; Humans; Imipenem; Infection Control; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Liver Transplantation; Male; Microbial Sensitivity Tests | 2010 |
Risk factors for hospital-acquired pneumonia caused by imipenem-resistant Pseudomonas aeruginosa in an intensive care unit.
Topics: Anti-Bacterial Agents; Case-Control Studies; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Imipenem; Intensive Care Units; Male; Middle Aged; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors | 2010 |
Risk factors for the acquisition of nosocomial infection with carbapenem-resistant Klebsiella pneumoniae.
Topics: Age Factors; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Case-Control Studies; Chi-Square Distribution; Confidence Intervals; Cross Infection; Drug Resistance, Bacterial; Ertapenem; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; Logistic Models; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Odds Ratio; Risk Factors; Thienamycins | 2011 |
Imipenem and ciprofloxacin consumption as factors associated with high incidence rates of resistant Pseudomonas aeruginosa in hospitals in northern France.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Cross Infection; Drug Resistance, Bacterial; Drug Utilization; France; Hospitals; Humans; Imipenem; Incidence; Pseudomonas aeruginosa; Pseudomonas Infections | 2011 |
Risk factors for mortality in patients with Pseudomonas aeruginosa bacteremia: clinical impact of antimicrobial resistance on outcome.
Topics: Adrenal Cortex Hormones; Aminoglycosides; Anti-Bacterial Agents; Catheters; Ceftazidime; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Humans; Imipenem; Male; Middle Aged; Piperacillin; Prevalence; Pseudomonas aeruginosa; Pseudomonas Infections; Republic of Korea; Retrospective Studies; Risk Factors; Survival Analysis; Treatment Outcome | 2011 |
Comparative activity of carbapenem testing: the COMPACT study.
Topics: Africa; Anti-Bacterial Agents; Carbapenems; Cross Infection; Doripenem; Europe; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Middle East; Thienamycins | 2011 |
Fluoroquinolone use is not associated with the change in imipenem susceptibility of Pseudomonas aeruginosa in 25 hospitals.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Fluoroquinolones; Hospitals, Teaching; Humans; Imipenem; Infection Control; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies | 2011 |
Emergence and dissemination of blaOXA-23-carrying imipenem-resistant Acinetobacter sp in a regional hospital in Taiwan.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Genotype; Hospitals, District; Humans; Imipenem; Molecular Typing; Multiplex Polymerase Chain Reaction; Sequence Analysis, DNA; Taiwan | 2011 |
Carbapenem-resistant Acinetobacter baumannii: diversity of resistant mechanisms and risk factors for infection.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Chi-Square Distribution; Cluster Analysis; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Imipenem; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Republic of Korea; Risk Factors; Statistics, Nonparametric; Thienamycins | 2012 |
Investigation and management of an imipenem-resistant oxa-23 Acinetobacter baumannii outbreak in an intensive care unit.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Case-Control Studies; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Female; Humans; Imipenem; Intensive Care Units; Male; Middle Aged; Young Adult | 2011 |
[Comparative evaluation of in vitro activities of carbapenems against gram-negative pathogens: Turkish data of COMPACT study].
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Cross Infection; Doripenem; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Intensive Care Units; Meropenem; Microbial Sensitivity Tests; Pneumonia, Bacterial; Thienamycins; Turkey | 2011 |
The impact of a nationwide antibiotic restriction program on antibiotic usage and resistance against nosocomial pathogens in Turkey.
Topics: Acinetobacter; Anti-Bacterial Agents; Cefepime; Ceftazidime; Ceftriaxone; Cephalosporins; Cost Savings; Cross Infection; Drug Costs; Drug Prescriptions; Drug Resistance, Bacterial; Drug Utilization; Escherichia; Health Policy; Hospitals; Humans; Imipenem; Klebsiella; Meropenem; Methicillin Resistance; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas; Staphylococcus aureus; Teicoplanin; Thienamycins; Turkey; Vancomycin | 2011 |
Risk factors for development of intestinal colonization with imipenem-resistant Pseudomonas aeruginosa in the intensive care unit setting.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Cohort Studies; Cross Infection; Female; Humans; Imipenem; Intensive Care Units; Intestines; Male; Middle Aged; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors | 2011 |
[Epidemiology and drug susceptibility of Pseudomonas aeruginosa strains isolated in the Chugoku region of Japan. Infection Forum in the Chugoku Region].
Topics: Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Cross Infection; Drug Resistance, Bacterial; Drug Resistance, Multiple; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Imipenem; Japan; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Sputum; Urine | 2011 |
Changes in antimicrobial susceptibility and major clones of Acinetobacter calcoaceticus-baumannii complex isolates from a single hospital in Korea over 7 years.
Topics: Acinetobacter; Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Genotype; Hospitals; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Republic of Korea; Species Specificity; Thienamycins | 2012 |
Emergence and clonal dissemination of carbapenem-hydrolysing OXA-58-producing Acinetobacter baumannii isolates in Bolivia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Bolivia; Carbapenems; Child; Child, Preschool; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Hospitals; Humans; Imipenem; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Middle Aged; Plasmids; Young Adult | 2012 |
Characteristics of carbapenem-resistant Acinetobacter spp. other than Acinetobacter baumannii in South Korea.
Topics: Acinetobacter; Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacteremia; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactam Resistance; Carbapenems; Cross Infection; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Imipenem; Microbial Sensitivity Tests; Polymerase Chain Reaction; Real-Time Polymerase Chain Reaction; Republic of Korea | 2012 |
Nosocomial outbreak of imipenem-resistant Pseudomonas aeruginosa producing VIM-2 metallo-β-lactamase in a kidney transplantation unit.
Topics: beta-Lactam Resistance; beta-Lactamases; Cross Infection; Disease Outbreaks; Electrophoresis, Gel, Pulsed-Field; Hospital Units; Humans; Imipenem; Kidney Transplantation; Polymerase Chain Reaction; Pseudomonas aeruginosa; Pseudomonas Infections; Tunisia | 2011 |
[Antibiotic susceptibility of isolates from blood of patients in intensive care units of emergency medical service].
Topics: Acetamides; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Candida; Cross Infection; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Infection Control; Intensive Care Units; Linezolid; Meropenem; Moscow; Oxazolidinones; Sepsis; Thienamycins; Vancomycin | 2011 |
Outbreak of imipenem-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex harboring different carbapenemase gene-associated genetic structures in an intensive care unit.
Topics: Acinetobacter baumannii; Acinetobacter calcoaceticus; Acinetobacter Infections; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Cluster Analysis; Cross Infection; Disease Outbreaks; Electrophoresis, Gel, Pulsed-Field; Environmental Microbiology; Female; Genes, Bacterial; Genetic Variation; Humans; Imipenem; Intensive Care Units; Male; Middle Aged; Molecular Epidemiology; Molecular Typing; Polymerase Chain Reaction; Taiwan | 2012 |
Comparative Activity of Carbapenem Testing (COMPACT) study in Germany.
Topics: Bacteremia; Carbapenems; Cross Infection; Doripenem; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Germany; Humans; Imipenem; Intensive Care Units; Intraabdominal Infections; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Quality Control; Thienamycins | 2012 |
A 9-Year retrospective review of antibiotic cycling in a surgical intensive care unit.
Topics: Anti-Bacterial Agents; Ceftazidime; Cilastatin; Cilastatin, Imipenem Drug Combination; Critical Care; Cross Infection; Drug Combinations; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Infection Control; Klebsiella Infections; Klebsiella pneumoniae; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Surgical Wound Infection | 2012 |
Investigation and control of an outbreak of imipenem-resistant Acinetobacter baumannii Infection in a Pediatric Intensive Care Unit.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Child; Child, Preschool; Cross Infection; Disease Outbreaks; Environmental Microbiology; Female; Humans; Imipenem; Infant; Infant, Newborn; Infection Control; Intensive Care Units, Pediatric; Male; Republic of Korea; Young Adult | 2012 |
Characterisation and clonal dissemination of OXA-23-producing Acinetobacter baumannii in Tabriz, northwest Iran.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; DNA Transposable Elements; DNA, Bacterial; Drug Resistance, Bacterial; Humans; Imipenem; Integrons; Iran; Microbial Sensitivity Tests; Molecular Epidemiology; Multiplex Polymerase Chain Reaction; Polymerase Chain Reaction; Sequence Analysis, DNA | 2012 |
Sequence type 101 (ST101) as the predominant carbapenem-non-susceptible Klebsiella pneumoniae clone in an acute general hospital in Italy.
Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Hospitals, General; Humans; Imipenem; Italy; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2012 |
Occurrence and phenotypic detection of class A carbapenemases among Escherichia coli and Klebsiella pneumoniae blood isolates at a tertiary care center.
Topics: Adult; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cross Infection; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Prevalence; Sepsis; Tertiary Care Centers; Thienamycins | 2013 |
Pan-β-lactam resistance development in Pseudomonas aeruginosa clinical strains: molecular mechanisms, penicillin-binding protein profiles, and binding affinities.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Binding Sites; Carbapenems; Ceftazidime; Cephalosporins; Cross Infection; Gene Expression; Humans; Imipenem; Kinetics; Microbial Sensitivity Tests; Penicillin-Binding Proteins; Protein Binding; Protein Isoforms; Pseudomonas aeruginosa; Pseudomonas Infections | 2012 |
Metallo- β - lactamase producing nonfermentative gram-negative bacteria: an increasing clinical threat among hospitalized patients.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cross Infection; Disk Diffusion Antimicrobial Tests; Humans; Imipenem; Pseudomonas aeruginosa; Pseudomonas Infections | 2012 |
[Do different interpretative methods used for evaluation of checkerboard synergy test affect the results?].
Topics: Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Sulbactam; Thienamycins | 2012 |
Dissemination of multidrug-resistant Acinetobacter baumannii carrying BlaOxA-23 from hospitals in central Taiwan.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Blotting, Southern; Cluster Analysis; Cross Infection; DNA Transposable Elements; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genotype; Hospitals, Teaching; Humans; Imipenem; Microbial Sensitivity Tests; Molecular Typing; Plasmids; Polymerase Chain Reaction; Sequence Analysis, DNA; Taiwan | 2013 |
Activities of doripenem against nosocomial bacteremic drug-resistant Gram-negative bacteria in a medical center in Taiwan.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cross Infection; Doripenem; Drug Resistance, Bacterial; Enterobacteriaceae; Gram-Negative Bacteria; Hospitals, University; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Taiwan; Thienamycins | 2012 |
[Changes of drug-resistance of Pseudomonas aeruginosa in pediatric intensive care unit].
Topics: Adolescent; Ampicillin; Anti-Bacterial Agents; Cefazolin; Child; Child, Preschool; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Imipenem; Infant; Intensive Care Units, Pediatric; Male; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections | 2012 |
Reducing risk of waterborne imipenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Cross Infection; Disease Outbreaks; Female; Humans; Imipenem; Male | 2013 |
Reply: Reducing risk of waterborne imipenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Cross Infection; Disease Outbreaks; Female; Humans; Imipenem; Male | 2013 |
Multidrug-resistant Acinetobacter baumannii infection following para-articular steroid injection in the knee--a case report.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; Colistin; Combined Modality Therapy; Cross Infection; Debridement; Drainage; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Female; Humans; Imipenem; Injections, Intra-Articular; Knee Joint; Magnetic Resonance Imaging; Microbial Sensitivity Tests; Steroids; Tendinopathy; Treatment Outcome | 2012 |
[Evaluation of Colistin-Ampicillin/Sulbactam Combination Efficacy in Imipenem-Resistant Acinetobacter baumannii Strains].
Topics: Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; Anti-Bacterial Agents; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Imipenem; Microbial Sensitivity Tests; Sulbactam | 2013 |
Cross-infection due to imipenem-resistant Bacteroides fragilis associated with a totally implantable venous port.
Topics: Adult; Aged; Aged, 80 and over; Bacteremia; Bacterial Proteins; Bacterial Typing Techniques; Bacteroides fragilis; Bacteroides Infections; beta-Lactamases; Catheterization, Central Venous; Cross Infection; DNA, Bacterial; Drug Resistance, Bacterial; Female; Genotype; Humans; Imipenem; Male; Middle Aged; Molecular Sequence Data; Neoplasms; Sequence Analysis, DNA; Thienamycins | 2002 |
Molecular characterization of bla(IMP-5), a new integron-borne metallo-beta-lactamase gene from an Acinetobacter baumannii nosocomial isolate in Portugal.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amino Acid Sequence; Anti-Bacterial Agents; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Cloning, Molecular; Cross Infection; Humans; Imipenem; Integrons; Molecular Sequence Data; Portugal | 2002 |
Severe nosocomial infections with imipenem-resistant Acinetobacter baumannii treated with ampicillin/sulbactam.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Ampicillin; Child; Cross Infection; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Middle Aged; Sulbactam | 2003 |
[Distribution of bacteria and analysis of their sensibility to antibiotics in patients with hospital-acquired pneumonia].
Topics: Adult; Aged; Aged, 80 and over; Cefoperazone; Ceftriaxone; Cross Infection; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus epidermidis | 2000 |
Nosocomial infectious potency of imipenem-resistant Pseudomonas aeruginosa isolated from obstetric and gynecologic infections.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cross Infection; Disease Outbreaks; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Imipenem; Microbial Sensitivity Tests; Obstetrics and Gynecology Department, Hospital; Polymerase Chain Reaction; Pseudomonas aeruginosa; Pseudomonas Infections | 2003 |
[Nosocomial infections caused by Acinetobacter: experience in a neonatal care unit in Casablanca].
Topics: Acinetobacter; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Cross Infection; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Infant, Newborn; Intensive Care Units, Neonatal; Morocco; Retrospective Studies | 2003 |
Determination of the frequency of inadequate antibiotic therapy using calculation of indication failure (IF), cumulative indication failure (CIF), and balanced indication failure (BIF).
Topics: Anti-Bacterial Agents; Bacterial Infections; Cefepime; Ceftazidime; Cephalosporins; Cross Infection; Drug Resistance, Multiple; Empiricism; Enterobacteriaceae Infections; Humans; Imipenem; Microbial Sensitivity Tests; Pneumonia, Bacterial; Treatment Failure | 2003 |
[Continuous surveillance of antimicrobial resistance among nosocomial gram-negative bacilli from intensive care units in China].
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Escherichia coli; Gram-Negative Bacteria; Humans; Imipenem; Intensive Care Units; Microbial Sensitivity Tests | 2003 |
Imipenem resistance in nonfermenters causing nosocomial urinary tract infections.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Bacterial; Gram-Negative Aerobic Bacteria; Humans; Imipenem; In Vitro Techniques; Microbial Sensitivity Tests; Urinary Tract Infections | 2003 |
Attributable costs and length of stay of an extended-spectrum beta-lactamase-producing Klebsiella pneumoniae outbreak in a neonatal intensive care unit.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cross Infection; Disease Outbreaks; Hospital Costs; Humans; Imipenem; Infant, Newborn; Intensive Care Units, Neonatal; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; New York City; Sentinel Surveillance | 2003 |
An outbreak of conjunctivitis caused by multiresistant Pseudomonas aeruginosa in a Brazilian newborn intensive care unit.
Topics: Anti-Bacterial Agents; Brazil; Ciprofloxacin; Conjunctivitis; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Infant, Newborn; Intensive Care Units, Neonatal; Pseudomonas aeruginosa; Pseudomonas Infections | 2003 |
Association between antecedent intravenous antimicrobial exposure and isolation of vancomycin-resistant enterococci.
Topics: Adult; Aged; Anti-Bacterial Agents; Case-Control Studies; Ceftazidime; Cross Infection; Enterococcus; Female; Gram-Positive Bacterial Infections; Hospitals, Urban; Humans; Imipenem; Infusions, Intravenous; Male; Middle Aged; Severity of Illness Index; Vancomycin; Vancomycin Resistance | 2003 |
Risk factors for acquisition of imipenem-resistant Acinetobacter baumannii: a case-control study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Case-Control Studies; Cephalosporins; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Imipenem; Intensive Care Units; Logistic Models; Male; Middle Aged; Risk Factors; Thienamycins | 2004 |
Clinical surveillance of surgical imipenem-resistant Pseudomonas aeruginosa infection in a Japanese hospital.
Topics: Anti-Bacterial Agents; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Drug Utilization Review; Electrophoresis, Gel, Pulsed-Field; Humans; Imipenem; Japan; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Surgical Wound Infection | 2004 |
[Investigation on the antibiotic resistance and risky factors of nosocomial infections caused by Stenotrophomonas maltophilia].
Topics: Antibiosis; Cilastatin; Cross Infection; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Imipenem; Microbial Sensitivity Tests; Risk Factors; Stenotrophomonas maltophilia | 2004 |
Risk factors and clinical outcomes of nosocomial multi-drug resistant Pseudomonas aeruginosa infections.
Topics: Adult; Age Factors; Aged; Anti-Bacterial Agents; Case-Control Studies; China; Comorbidity; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Hospitals, University; Humans; Imipenem; Logistic Models; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Respiration, Artificial; Risk Factors; Thienamycins; Treatment Outcome | 2004 |
Typing and characterization of carbapenem-resistant Acinetobacter calcoaceticus-baumannii complex in a Chinese hospital.
Topics: Acinetobacter baumannii; Acinetobacter calcoaceticus; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; Carbapenems; China; Clavulanic Acid; Cloxacillin; Cross Infection; DNA Fingerprinting; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enzyme Inhibitors; Genes, Bacterial; Genotype; Imipenem; Isoelectric Focusing; Isoelectric Point; Microbial Sensitivity Tests; Molecular Epidemiology; Sequence Analysis, DNA | 2004 |
Long-term dissemination of an OXA-40 carbapenemase-producing Acinetobacter baumannii clone in the Iberian Peninsula.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacterial Proteins; beta-Lactamases; Chromosomes, Bacterial; Cross Infection; DNA Fingerprinting; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Imipenem; Microbial Sensitivity Tests; Portugal; Reverse Transcriptase Polymerase Chain Reaction; Spain | 2004 |
[Carbapenemase detection in Acinetobacter baumannii clones resistant to imipenem].
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Genotype; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Multicenter Studies as Topic; Spain; Thienamycins | 2004 |
Outbreak of multidrug resistant Acinetobacter in the neonatal intensive care unit.
Topics: Acinetobacter Infections; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Drug Resistance, Multiple; Female; Humans; Imipenem; Infant, Newborn; Infant, Premature, Diseases; Intensive Care Units, Neonatal; Intubation, Intratracheal; Male; Risk Factors; Saudi Arabia; Survival Rate | 2004 |
In vitro activity and killing effect of the synthetic hybrid cecropin A-melittin peptide CA(1-7)M(2-9)NH(2) on methicillin-resistant nosocomial isolates of Staphylococcus aureus and interactions with clinically used antibiotics.
Topics: Amoxicillin-Potassium Clavulanate Combination; Cross Infection; Drug Interactions; Female; Humans; Imipenem; Male; Melitten; Methicillin Resistance; Microbial Sensitivity Tests; Sensitivity and Specificity; Staphylococcal Infections; Staphylococcus aureus | 2004 |
Morphological changes induced by imipenem and meropenem at sub-inhibitory concentrations in Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Carbapenems; Cross Infection; Histocytochemistry; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Pneumonia; Thienamycins | 2004 |
Metallo-beta-lactamase-producing Gram-negative bacilli in Korean Nationwide Surveillance of Antimicrobial Resistance group hospitals in 2003: continued prevalence of VIM-producing Pseudomonas spp. and increase of IMP-producing Acinetobacter spp.
Topics: Acinetobacter; Anti-Bacterial Agents; beta-Lactamases; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacteria; Humans; Imipenem; Korea; Male; Microbial Sensitivity Tests; Multicenter Studies as Topic; Population Surveillance; Pseudomonas; Sensitivity and Specificity | 2004 |
An outbreak of imipenem-resistant Pseudomonas aeruginosa in an intensive care unit.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Bacterial; England; Humans; Imipenem; Infection Control; Intensive Care Units; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections | 2004 |
Nosocomial bloodstream infections with Burkholderia stabilis.
Topics: Adolescent; Adult; Aged; Bacteremia; Bacterial Typing Techniques; Burkholderia; Burkholderia Infections; Ciprofloxacin; Cross Infection; Drug Resistance, Bacterial; Drug Therapy, Combination; Hospital Mortality; Hospitals, University; Humans; Imipenem; Infection Control; Intensive Care Units; Male; Middle Aged; Opportunistic Infections; Random Amplified Polymorphic DNA Technique; Retrospective Studies; Risk Factors; Treatment Outcome; Turkey | 2005 |
A nosocomial outbreak of Acinetobacter baumannii isolates expressing the carbapenem-hydrolysing oxacillinase OXA-58.
Topics: Acinetobacter baumannii; Acinetobacter Infections; beta-Lactamases; Burn Units; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; France; Hospitals, University; Humans; Imipenem; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction; Sequence Analysis, DNA | 2005 |
Risk factors for imipenem-resistant Pseudomonas aeruginosa: a comparative analysis of two case-control studies in hospitalized patients.
Topics: Anti-Bacterial Agents; Brazil; Case-Control Studies; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Imipenem; Logistic Models; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors | 2005 |
[Analysis of the distribution characteristics and drug sensitivity of infection pathogens in hematology department ward].
Topics: Cross Infection; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; Hematologic Diseases; Humans; Imipenem; Microbial Sensitivity Tests; Vancomycin | 2004 |
Postantibiotic effect of antimicrobial combinations on multidrug-resistant Pseudomonas aeruginosa.
Topics: Amikacin; Ceftazidime; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Sensitivity and Specificity | 2005 |
Early antibiotic treatment for BAL-confirmed ventilator-associated pneumonia: a role for routine endotracheal aspirate cultures.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteriological Techniques; Bronchoalveolar Lavage Fluid; Cephalosporins; Cross Infection; Early Diagnosis; Female; France; Humans; Imipenem; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Penicillins; Pneumonia, Bacterial; Population Surveillance; Practice Guidelines as Topic; Prospective Studies; Pseudomonas Infections; Treatment Outcome; Ventilators, Mechanical | 2005 |
Risk factors for ICU-acquired imipenem-resistant Gram-negative bacterial infections.
Topics: Anti-Bacterial Agents; Case-Control Studies; Cross Infection; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Infection Control; Intensive Care Units; Length of Stay; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Risk Factors; Surgical Wound Infection; Turkey | 2005 |
Acinetobacter baumannii ventilator-associated pneumonia: epidemiological and clinical findings.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Imipenem; Male; Middle Aged; Multivariate Analysis; Pneumonia, Bacterial; Prognosis; Prospective Studies; Regression Analysis; Respiration, Artificial; Retrospective Studies; Risk Factors; Spain | 2005 |
[Germs that produce the extended spectrum betalactamases].
Topics: Acute Disease; Adolescent; Adult; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Cross Infection; Emergencies; Escherichia coli; Escherichia coli Infections; Female; Hospitals, University; Humans; Imipenem; Leukemia; Lymphoma, Non-Hodgkin; Male; Morocco; Neutropenia; Retrospective Studies; Shock, Septic; Time Factors | 2004 |
Identification of an imipenem-resistant Pseudomonas aeruginosa clone among patients in a hospital in Rio de Janeiro.
Topics: Brazil; Colony Count, Microbial; Cross Infection; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genetic Variation; Genotype; Health Services Needs and Demand; Hospitals, Military; Hospitals, University; Humans; Imipenem; Immunodiffusion; Infection Control; Microbial Sensitivity Tests; Molecular Epidemiology; Phylogeny; Pseudomonas aeruginosa; Pseudomonas Infections; Restriction Mapping; Time Factors | 2005 |
Investigation of a nosocomial outbreak of imipenem-resistant Acinetobacter baumannii producing the OXA-23 beta-lactamase in korea.
Topics: Acinetobacter baumannii; Base Sequence; beta-Lactamases; Conjugation, Genetic; Cross Infection; DNA Primers; Drug Resistance, Microbial; Genotype; Humans; Imipenem; Korea; Microbial Sensitivity Tests | 2005 |
Hospital-acquired pneumonia in critically ill patients: factors associated with episodes due to imipenem-resistant organisms.
Topics: Acinetobacter baumannii; Aged; Anti-Bacterial Agents; Critical Illness; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Imipenem; Male; Middle Aged; Pneumonia, Bacterial; Pseudomonas aeruginosa; Risk Factors; Staphylococcus aureus; Stenotrophomonas maltophilia | 2005 |
Hospital outbreak caused by a carbapenem-resistant strain of Acinetobacter baumannii: patient prognosis and risk-factors for colonisation and infection.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Carbapenems; Case-Control Studies; Catheterization, Peripheral; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Female; Humans; Hypotension; Imipenem; Logistic Models; Male; Risk Factors; Shock; Spain | 2005 |
The risk factors for acquisition of imipenem-resistant Pseudomonas aeruginosa in the burn unit.
Topics: Adolescent; Anti-Bacterial Agents; Burn Units; Burns; Case-Control Studies; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Imipenem; Length of Stay; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Risk Factors | 2005 |
Metallo-beta-lactamase IMP-1 in Providencia rettgeri from two different hospitals in Japan.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Conjugation, Genetic; Cross Infection; DNA Fingerprinting; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae Infections; Escherichia coli; Humans; Imipenem; Integrons; Japan; Molecular Epidemiology; Plasmids; Polymerase Chain Reaction; Providencia; Sequence Analysis, DNA | 2005 |
Nosocomial spread of Pseudomonas aeruginosa isolates expressing the metallo-beta-lactamase VIM-2 in a hematology unit of a French hospital.
Topics: beta-Lactamases; Ceftazidime; Cross Infection; DNA, Bacterial; Drug Resistance, Bacterial; France; Hematology; Hospitals; Humans; Imipenem; Integrons; Plasmids; Pseudomonas aeruginosa; Pseudomonas Infections | 2005 |
Pharmacodynamics of antimicrobials for the empirical treatment of nosocomial pneumonia: a report from the OPTAMA Program.
Topics: Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Ciprofloxacin; Cross Infection; Dose-Response Relationship, Drug; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Monte Carlo Method; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; Thienamycins | 2005 |
Risk-factors for the acquisition of imipenem-resistant Acinetobacter baumannii in Spain: a nationwide study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Catheters, Indwelling; Cross Infection; Disease Transmission, Infectious; DNA Fingerprinting; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Hospital Bed Capacity; Hospitals; Humans; Imipenem; Inpatients; Risk Factors; Spain; Surgical Wound Infection | 2005 |
Systemic inflammatory response syndrome in adult patients with nosocomial bloodstream infection due to Pseudomonas aeruginosa.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Imipenem; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Systemic Inflammatory Response Syndrome; Time Factors | 2006 |
Imipenem-resistant Achromobacter xylosoxidans carrying blaVIM-2-containing class 1 integron.
Topics: Achromobacter denitrificans; Anti-Bacterial Agents; beta-Lactamases; Cross Infection; Gram-Negative Bacterial Infections; Hospitals, University; Humans; Imipenem; Integrons; Korea; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA | 2005 |
Spread of an unusual penicillin- and imipenem-resistant but ampicillin-susceptible phenotype among Enterococcus faecalis clinical isolates.
Topics: Ampicillin; Anti-Bacterial Agents; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Gram-Positive Bacterial Infections; Greece; Hospitals, University; Humans; Imipenem; Microbial Sensitivity Tests; Penicillins | 2006 |
[Infections caused by Acinetobacter spp. in critically ill ICU patients].
Topics: Acinetobacter; Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; APACHE; Bacteremia; beta-Lactam Resistance; Child; Comorbidity; Critical Illness; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Health Surveys; Hospital Mortality; Humans; Imipenem; Incidence; Intensive Care Units; Male; Middle Aged; Postoperative Complications; Prospective Studies; Prosthesis-Related Infections; Spain; Species Specificity | 2005 |
[A case-control study on the risk factors of nosocomial infection caused by imipenem-resistant Pseudomonas aeruginosa].
Topics: Case-Control Studies; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Imipenem; Logistic Models; Male; Middle Aged; Multivariate Analysis; Pseudomonas aeruginosa; Risk Factors | 2005 |
Integron-associated imipenem resistance in Acinetobacter baumannii isolated from a regional hospital in Taiwan.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Gene Order; Humans; Imipenem; Integrons; Plasmids; Polymerase Chain Reaction; Taiwan | 2006 |
Alert surveillance of intensive care unit-acquired Acinetobacter infections in a Sicilian hospital.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Gene Transfer, Horizontal; Humans; Imipenem; Integrons; Intensive Care Units; Italy; Meropenem; Morbidity; Pneumonia, Bacterial; Thienamycins | 2006 |
[Drug susceptibility of Pseudomonas aeruginosa strains isolated from patients of a hospital and specialistic outpatients clinics of the SP ZOZ in Nidzica].
Topics: Adult; Anti-Bacterial Agents; Child; Cross Infection; Drug Resistance, Bacterial; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 2005 |
Multidrug-resistant bacteria isolated from patients hospitalised in Intensive Care Units.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Cross Infection; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Imipenem; Inpatients; Intensive Care Units; Length of Stay; Microbial Sensitivity Tests; Risk Factors | 2006 |
A clinicomicrobiological study on the importance of pseudomonas in nosocomially infected ICU patients, with special reference to metallo beta1-lactamase production.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbenicillin; Cross Infection; Hospitals, Teaching; Humans; Imipenem; India; Inpatients; Intensive Care Units; Microbial Sensitivity Tests; Polymyxin B; Pseudomonas; Pseudomonas Infections; Trachea | 2006 |
[Contribution of Pseudomonas Aeruginosa strains to infections in patients of specialistic outpatients clinics of the SP ZOZ in Nidzica].
Topics: Adult; Ambulatory Care Facilities; Anti-Bacterial Agents; Child; Cross Infection; Humans; Imipenem; Microbial Sensitivity Tests; Poland; Pseudomonas aeruginosa; Pseudomonas Infections; Species Specificity | 2005 |
Emergence of Proteus mirabilis carrying the bla metallo-beta-lactamase gene.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cross Infection; Humans; Imipenem; Microbial Sensitivity Tests; Proteus Infections; Proteus mirabilis | 2006 |
Acquisition of imipenem-resistant Acinetobacter baumannii in a pediatric intensive care unit: A case-control study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Case-Control Studies; Chi-Square Distribution; Child; Child, Preschool; Cross Infection; Drug Resistance, Bacterial; Female; Greece; Humans; Imipenem; Intensive Care Units, Pediatric; Length of Stay; Logistic Models; Male; Retrospective Studies; Risk Factors | 2006 |
Prospective determination of plasma imipenem concentrations in critically ill children.
Topics: Anti-Bacterial Agents; Area Under Curve; Bacterial Infections; Child; Child, Preschool; Cilastatin; Cilastatin, Imipenem Drug Combination; Critical Illness; Cross Infection; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Infant; Infant, Newborn; Infusions, Intravenous; Male | 2006 |
Imipenem resistance among pseudomonas aeruginosa isolates: risk factors for infection and impact of resistance on clinical and economic outcomes.
Topics: Adult; Aged; Case-Control Studies; Cohort Studies; Cross Infection; Drug Resistance, Bacterial; Humans; Imipenem; Middle Aged; Pennsylvania; Prevalence; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors | 2006 |
Outbreaks of imipenem-resistant Acinetobacter baumannii producing carbapenemases in Korea.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Korea; Phenotype; Polymerase Chain Reaction | 2006 |
[Nosocomial respiratory infection due to an imipenem-resistant Pseudomonas aeruginosa O: 12 strain in a Tunis's neonatal intensive care unit].
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Bacterial; Humans; Imipenem; Infant, Newborn; Intensive Care Units, Neonatal; Pseudomonas aeruginosa; Pseudomonas Infections; Tunisia | 2006 |
Successful use of sodium hypochlorite pack plus systemic and local antibiotic therapy for the treatment of pseudomonas infection of peritoneal dialysis catheter exit-site.
Topics: Anti-Bacterial Agents; Catheters, Indwelling; Cilastatin; Cross Infection; Disinfectants; Drug Therapy, Combination; Humans; Imipenem; Infection Control; Kidney Failure, Chronic; Peritoneal Dialysis; Peritonitis; Pseudomonas Infections; Sodium Hypochlorite | 2007 |
A statistical method for estimating the proportion of cases resulting from cross-transmission of multi-resistant pathogens in an intensive care unit.
Topics: Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Infection Control; Intensive Care Units; Methicillin Resistance; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Statistics as Topic | 2007 |
[Status of nosocomial urinary tract infections in the ICU: molecular epidemiology of imipenem resistant P. aeruginosa].
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Imipenem; Intensive Care Units; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Risk Factors; Urinary Catheterization; Urinary Tract Infections | 2006 |
Prospective evaluation of imipenem/EDTA combined disc and Etest for detection of metallo-beta-lactamase-producing Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; beta-Lactamases; Chelating Agents; Cross Infection; Drug Resistance, Bacterial; Edetic Acid; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Reverse Transcriptase Polymerase Chain Reaction; Spectrophotometry, Ultraviolet | 2007 |
Molecular characterization of imipenem-resistant Pseudomonas aeruginosa in Hiroshima, Japan.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Imipenem; Japan; Male; Multigene Family; Phylogeny; Pseudomonas aeruginosa; Pseudomonas Infections | 2007 |
Risk factors for nosocomial imipenem-resistant Acinetobacter baumannii infections.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Case-Control Studies; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Hospitals, Teaching; Humans; Imipenem; Intensive Care Units; Length of Stay; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Risk Factors; Sentinel Surveillance; Turkey | 2008 |
Widespread occurrence of aminoglycoside resistance due to ArmA methylase in imipenem-resistant Acinetobacter baumannii isolates in China.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aminoglycosides; Anti-Bacterial Agents; China; Cross Infection; Drug Resistance, Bacterial; Escherichia coli Proteins; Humans; Imipenem; Methyltransferases; Reverse Transcriptase Polymerase Chain Reaction | 2007 |
Mortality following bacteraemic infection caused by extended spectrum beta-lactamase (ESBL) producing E. coli compared to non-ESBL producing E. coli.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Bile Duct Diseases; Community-Acquired Infections; Cross Infection; Drug Resistance; England; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Length of Stay; Male; Middle Aged; Odds Ratio; Prospective Studies; Urinary Tract Infections | 2007 |
High prevalence of metallo-beta-lactamase and 16S rRNA methylase coproduction among imipenem-resistant Pseudomonas aeruginosa isolates in Brazil.
Topics: Anti-Bacterial Agents; beta-Lactamases; Brazil; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Polyacrylamide Gel; Humans; Imipenem; Methyltransferases; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Reverse Transcriptase Polymerase Chain Reaction | 2007 |
[Antibmicrobial susceptibility of Serratia marcescens isolated from hospitalized patients in 2003 - 2005].
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Ciprofloxacin; Cross Infection; Disk Diffusion Antimicrobial Tests; Drug Resistance, Multiple, Bacterial; Gentamicins; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Poland; Serratia marcescens; Thienamycins | 2007 |
[Infectivity and resistance to antibiotics of bacterial strains isolated from patients hospitalised in intensive care units].
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bronchi; Child; Child, Preschool; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacteria; Gram-Positive Cocci; Humans; Imipenem; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Respiratory Tract Infections; Species Specificity; Virulence | 2007 |
Molecular typing of imipenem-resistant Acinetobacter baumannii-calcoaceticus complex in a Singapore hospital where carbapenem resistance is endemic.
Topics: Acinetobacter baumannii; Acinetobacter calcoaceticus; Acinetobacter Infections; Anti-Bacterial Agents; Carbenicillin; Cross Infection; Genotype; Humans; Imipenem; Penicillin Resistance; Phylogeny; Prospective Studies; Singapore | 2007 |
Implementation of antibiotic rotation protocol improves antibiotic susceptibility profile in a surgical intensive care unit.
Topics: Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Clinical Protocols; Critical Care; Cross Infection; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Incidence; Intensive Care Units; Male; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Probability; Retrospective Studies; Sensitivity and Specificity; Tazobactam; Treatment Outcome | 2007 |
[The frequency of PER-1 type extended spectrum beta-lactamases in nosocomial isolates of Pseudomonas aeruginosa].
Topics: Anti-Bacterial Agents; beta-Lactamases; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Imipenem; Meropenem; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Polymerase Chain Reaction; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins; Tobramycin | 2007 |
Clonal spread of imipenem-resistant Acinetobacter baumannii among different cities of China.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; China; Cross Infection; Disease Outbreaks; DNA Transposable Elements; DNA, Bacterial; Drug Resistance, Bacterial; Humans; Imipenem; Molecular Sequence Data; Sequence Analysis, DNA | 2007 |
Dissemination of Pseudomonas aeruginosa producing SPM-1-like and IMP-1-like metallo-beta-lactamases in hospitals from southern Brazil.
Topics: Anti-Bacterial Agents; beta-Lactamases; Brazil; Ceftazidime; Cross Infection; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Hospitals, Teaching; Humans; Imipenem; Polymerase Chain Reaction; Pseudomonas aeruginosa; Pseudomonas Infections | 2007 |
An outbreak of imipenem-resistant Acinetobacter baumannii at Songklanagarind Hospital: the risk factors and patient prognosis.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; Case-Control Studies; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Female; Humans; Imipenem; Male; Middle Aged; Prognosis; Retrospective Studies; Risk Factors; Thailand | 2007 |
[Imipenem resistance in Gram-negative rods and its consumption between 1999 and 2005].
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactam Resistance; Carbapenems; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacterial Infections; Humans; Imipenem; Intensive Care Units; Microbial Sensitivity Tests; Retrospective Studies | 2007 |
Genetic diversity of carbapenem-resistant isolates of Acinetobacter baumannii in Europe.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactam Resistance; Carbapenems; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Europe; Genetic Variation; Geography; Humans; Imipenem; Microbial Sensitivity Tests; Random Amplified Polymorphic DNA Technique | 2008 |
Susceptibility of bacterial isolates from Turkey--a report from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Program.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Humans; Imipenem; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Thienamycins; Turkey | 2007 |
Genodiversity of resistant Pseudomonas aeruginosa isolates in relation to antimicrobial usage density and resistance rates in intensive care units.
Topics: Anti-Infective Agents; Ciprofloxacin; Cross Infection; Drug Resistance, Bacterial; Drug Utilization; Genetic Variation; Germany; Humans; Imipenem; Intensive Care Units; Prospective Studies; Pseudomonas aeruginosa; Sentinel Surveillance | 2008 |
Nosocomial acquisition of Pseudomonas aeruginosa resistant to both ciprofloxacin and imipenem: a risk factor and laboratory analysis.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Blotting, Western; Case-Control Studies; Ciprofloxacin; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Imipenem; Intensive Care Units; Male; Middle Aged; Porins; Pseudomonas aeruginosa; Pseudomonas Infections | 2008 |
[Antibiotic susceptibility and molecular mechanisms of cephalosporins resistance in Klebsiella isolates from patients with hospital-acquired infections].
Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporin Resistance; Cross Infection; Humans; Imipenem; Klebsiella; Klebsiella Infections; Meropenem; Thienamycins | 2006 |
A pharmacodynamic simulation to assess tigecycline efficacy for hospital-acquired pneumonia compared with other common intravenous antibiotics.
Topics: Anti-Bacterial Agents; Cross Infection; Humans; Imipenem; Levofloxacin; Microbial Sensitivity Tests; Minocycline; Models, Biological; Monte Carlo Method; Ofloxacin; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia; Tigecycline | 2008 |
Clusters of imipenem-resistant Acinetobacter baumannii clones producing different carbapenemases in an intensive care unit.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cluster Analysis; Cross Infection; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Genes, Bacterial; Greece; Hospitals, General; Humans; Imipenem; Incidence; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Opportunistic Infections; Sentinel Surveillance; Sequence Analysis, DNA | 2008 |
Controlling the clonal spread of Pseudomonas aeruginosa infection.
Topics: Anti-Bacterial Agents; Case-Control Studies; Cross Infection; Drug Resistance, Bacterial; Female; Genotype; Humans; Imipenem; Infection Control; Length of Stay; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors | 2008 |
In vitro activity of N-formimidoyl-thienamycin in comparison to that of moxalactam and cefotaxime against gentamicin-resistant gram-negative bacteria.
Topics: Acinetobacter; Bacteria; Cefotaxime; Cephalosporins; Cephamycins; Cross Infection; Drug Resistance, Microbial; Enterobacter; Escherichia coli; Gentamicins; Imipenem; Klebsiella; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa; Serratia; Thienamycins | 1982 |
Activity of N-formimidoyl thienamycin and cephalosporins against isolates from nosocomially acquired bacteremia.
Topics: Anti-Bacterial Agents; Bacteria; Cephalosporins; Cross Infection; Humans; Imipenem; Lactams; Microbial Sensitivity Tests; Sepsis | 1982 |
Outbreak caused by two multi-resistant Acinetobacter baumannii clones in a burns unit: emergence of resistance to imipenem.
Topics: Acinetobacter; Acinetobacter Infections; Bacterial Typing Techniques; beta-Lactam Resistance; Burns; Cross Infection; Disease Outbreaks; Humans; Imipenem; Infection Control; Microbial Sensitivity Tests; Thienamycins | 1995 |
Development of resistance to imipenem among nosocomial isolates of Pseudomonas aeruginosa.
Topics: beta-Lactam Resistance; Cross Infection; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins | 1995 |
Comparative in vitro killing activity of meropenem versus imipenem against multiresistant nosocomial Pseudomonas aeruginosa.
Topics: Cross Infection; Drug Resistance, Microbial; Drug Resistance, Multiple; Humans; Imipenem; In Vitro Techniques; Meropenem; Pseudomonas Infections; Thienamycins; Time Factors | 1995 |
An outbreak of Enterobacter cloacae associated with contamination of a blood gas machine.
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Typing Techniques; Blood Gas Analysis; Cross Infection; Disease Outbreaks; Enterobacter cloacae; Enterobacteriaceae Infections; Equipment Contamination; Gentamicins; Humans; Imipenem; Infant; Infant, Newborn; Infection Control; Thienamycins | 1995 |
Antibiotic-resistant Acinetobacter meningitis in neurosurgical patients.
Topics: Acinetobacter Infections; Adult; Aged; Amikacin; Anti-Bacterial Agents; Bacteremia; Bacteriological Techniques; Brain Diseases; Brain Neoplasms; Cross Infection; Drug Resistance, Microbial; Female; Humans; Imipenem; Male; Meningitis, Bacterial; Middle Aged; Postoperative Complications; Recurrence; Risk Factors; Surgical Wound Infection | 1994 |
Characterization of a hospital outbreak of imipenem-resistant Acinetobacter baumannii by phenotypic and genotypic typing methods.
Topics: Acinetobacter; Bacterial Typing Techniques; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Genotype; Humans; Imipenem; Phenotype | 1994 |
Antimicrobial activity of cefepime tested against Bush group I beta-lactamase-producing strains resistant to ceftazidime. A multilaboratory national and international clinical isolate study.
Topics: beta-Lactamases; Cefepime; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Ciprofloxacin; Cross Infection; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; International Cooperation; Microbial Sensitivity Tests | 1994 |
Clinical and molecular epidemiology of acinetobacter infections sensitive only to polymyxin B and sulbactam.
Topics: Acinetobacter; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Cross Infection; Disease Outbreaks; DNA, Bacterial; Environmental Microbiology; Humans; Imipenem; Microbial Sensitivity Tests; Middle Aged; New York; Polymyxin B; Sulbactam | 1994 |
Infections caused by imipenem-resistant Acinetobacter calcoaceticus biotype anitratus.
Topics: Acinetobacter calcoaceticus; Acinetobacter Infections; Adult; Aged; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Humans; Imipenem; Male | 1993 |
Activity of imipenem, third-generation cephalosporins, aztreonam and ciprofloxacin against multi-resistant gram-negative bacilli isolated from Chilean hospitals.
Topics: Anti-Bacterial Agents; Aztreonam; Cephalosporins; Chile; Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Drug Synergism; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Indicators and Reagents; Microbial Sensitivity Tests | 1993 |
Cross-susceptibility of cefpirome and four other beta-lactams against isolates from haematology/oncology and intensive care units. International Study Group.
Topics: Anti-Bacterial Agents; Bacterial Infections; Cefpirome; Ceftazidime; Ceftriaxone; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Europe; Gram-Negative Bacteria; Gram-Positive Bacteria; Hospital Units; Humans; Imipenem; Intensive Care Units; Microbial Sensitivity Tests; Piperacillin; Prevalence | 1993 |
Clinical and bacteriological study of nosocomial infections due to Enterobacter aerogenes resistant to imipenem.
Topics: Bacterial Outer Membrane Proteins; Bacterial Typing Techniques; beta-Lactamases; Cephalosporinase; Cilastatin; Cilastatin, Imipenem Drug Combination; Cross Infection; Drug Combinations; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids | 1993 |
Effect of sulbactam on infections caused by imipenem-resistant Acinetobacter calcoaceticus biotype anitratus.
Topics: Acinetobacter calcoaceticus; Acinetobacter Infections; Ampicillin; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Imipenem; Microbial Sensitivity Tests; Retrospective Studies; Sulbactam | 1993 |
Transferable resistance to imipenem in hospital isolates of Pseudomonas aeruginosa.
Topics: Conjugation, Genetic; Cross Infection; Drug Resistance, Microbial; Humans; Imipenem; Pseudomonas aeruginosa; Pseudomonas Infections; Species Specificity; Time Factors | 1993 |
Emergence of bacterial resistance to imipenem and ciprofloxacin in a university hospital.
Topics: Anti-Infective Agents; Bacteria; Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Drug Utilization; Humans; Imipenem; Microbial Sensitivity Tests; Norfloxacin; Oxacillin; Penicillins; Thienamycins | 1995 |
Increasing incidence of carbapenem-resistant Pseudomonas aeruginosa bacteraemia in a cancer centre over a seven-year period.
Topics: Bacteremia; Carbapenems; Cross Infection; Drug Resistance, Microbial; Humans; Imipenem; Incidence; Pseudomonas Infections; Retrospective Studies; Thienamycins | 1997 |
Hydrolysis of imipenem, meropenem, ceftazidime, and cefepime by multiresistant nosocomial strains of Sphingobacterium multivorum.
Topics: Cefepime; Ceftazidime; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Drug Resistance, Multiple; Flavobacterium; Gram-Negative Bacterial Infections; Humans; Hydrolysis; Imipenem; Meropenem; Microbial Sensitivity Tests; Thienamycins | 1997 |
Antimicrobial resistance in isolates from inpatients and outpatients in the United States: increasing importance of the intensive care unit.
Topics: Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Enterococcus; Humans; Imipenem; Intensive Care Units; Outpatients; Pseudomonas aeruginosa; Vancomycin | 1997 |
Comparison of treatment with imipenem vs. ceftazidime as a predisposing factor for nosocomial acquisition of Stenotrophomonas maltophilia: a historical cohort study.
Topics: Anti-Bacterial Agents; Ceftazidime; Cohort Studies; Cross Infection; Female; Humans; Imipenem; Male; Middle Aged; Xanthomonas | 1997 |
Secular trends in bloodstream infection caused by antimicrobial-resistant bacteria in New Jersey hospitals, 1991 to 1995.
Topics: Bacteremia; Cross Infection; Data Collection; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterococcus; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals, Private; Humans; Imipenem; Microbial Sensitivity Tests; New Jersey; Penicillin Resistance; Pneumococcal Infections; Prevalence; Species Specificity; Streptococcus pneumoniae; Vancomycin | 1997 |
Piperacillin/tazobactam in the treatment of Klebsiella pneumoniae infections in neonates.
Topics: Anti-Infective Agents; beta-Lactamase Inhibitors; Cilastatin; Ciprofloxacin; Cross Infection; Drug Combinations; Drug Resistance, Microbial; Drug Resistance, Multiple; Enzyme Inhibitors; Female; Humans; Imipenem; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Protease Inhibitors; Retrospective Studies; Tazobactam; Thienamycins | 1998 |
Gram-negative bacilli isolated from patients in intensive care unit: prevalence and antibiotic susceptibility.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Blood; Carbapenems; Cephalosporins; Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Gram-Negative Bacteria; Humans; Imipenem; Intensive Care Units; Microbial Sensitivity Tests; Respiratory Tract Infections; Saudi Arabia; Urinary Tract Infections; Wounds and Injuries | 1997 |
[Comparative activity of meropenem and other antibiotics against the pathogens of nosocomial infections].
Topics: Anti-Bacterial Agents; Cephalosporins; Cross Infection; Drug Therapy, Combination; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Imipenem; Meropenem; Microbial Sensitivity Tests; Thienamycins; Tobramycin | 1998 |
Imipenem resistance in aerobic gram-negative bacteria.
Topics: beta-Lactam Resistance; Burn Units; Burns; Cross Infection; Gram-Negative Aerobic Bacteria; Humans; Imipenem; Kuwait; Microbial Sensitivity Tests; Prospective Studies; Thienamycins | 1998 |
Transduction of antibiotic resistance including imipenem resistance by wild type phages from nosocomial strains of Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Carbenicillin; Cross Infection; Drug Resistance, Microbial; Drug Resistance, Multiple; Gentamicins; Humans; Imipenem; Penicillin Resistance; Penicillins; Pseudomonas aeruginosa; Pseudomonas Infections; Pseudomonas Phages; Thienamycins; Transduction, Genetic | 1997 |
[Imipenem resistance in Pseudomonas aeruginosa].
Topics: Austria; Bacterial Typing Techniques; Cross Infection; Drug Resistance, Microbial; Humans; Imipenem; Meropenem; Polymorphism, Restriction Fragment Length; Pseudomonas Infections; Thienamycins | 1998 |
[Susceptibility of clinical strains of gram-positive bacteria to selected beta-lactam antibiotics].
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Clavulanic Acids; Cross Infection; Drug Resistance, Microbial; Drug Therapy, Combination; Gram-Positive Bacteria; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Species Specificity; Thienamycins; Ticarcillin | 1998 |
Utility of serial rectal swab cultures for detection of ceftazidime- and imipenem-resistant gram-negative bacilli from patients in the intensive care unit.
Topics: Adult; Aged; beta-Lactam Resistance; Ceftazidime; Cephalosporins; Cross Infection; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Intensive Care Units; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Rectum; Thienamycins | 1998 |
Molecular characterization of epidemic multiresistant Staphylococcus haemolyticus isolates.
Topics: Ampicillin; Anti-Bacterial Agents; Cefazolin; Cefmetazole; Cross Infection; DNA Restriction Enzymes; Drug Resistance, Microbial; Drug Resistance, Multiple; Electrophoresis, Gel, Pulsed-Field; Gentamicins; Hospital Bed Capacity, 500 and over; Humans; Imipenem; Infant, Newborn; Microbial Sensitivity Tests; Neonatal Nursing; Nursing Staff, Hospital; Ofloxacin; Oxacillin; Phylogeny; Staphylococcal Infections; Staphylococcus; Tobramycin; Vancomycin | 1998 |
Epidemiological analysis of imipenem-resistant Serratia marcescens in hospitalized patients.
Topics: Boston; Case-Control Studies; Cross Infection; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Imipenem; Intensive Care Units; Male; Medical Records; Microbial Sensitivity Tests; Middle Aged; Serratia Infections; Serratia marcescens; Thienamycins | 1999 |
[Imipenem. Evaluation of its role in antibacterial therapy of severe hospital infections].
Topics: Cross Infection; Dose-Response Relationship, Drug; Economics, Pharmaceutical; Humans; Imipenem; Microbial Sensitivity Tests; Thienamycins | 1999 |
Control of a prolonged outbreak of extended-spectrum beta-lactamase-producing enterobacteriaceae in a university hospital.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals, University; Humans; Imipenem; Infection Control; Intensive Care Units; Paris | 1999 |
Prevalent nosocomial gram negative aerobic bacilli and their antimicrobial susceptibility pattern in intensive care unit.
Topics: Amikacin; Anti-Bacterial Agents; Cross Infection; Gram-Negative Bacterial Infections; Humans; Imipenem; Infant, Newborn; Intensive Care Units; Microbial Sensitivity Tests; Prospective Studies; Thienamycins | 1999 |
Bacillus cereus fatal bacteremia and apparent association with nosocomial transmission in an intensive care unit.
Topics: Adenocarcinoma; Anti-Bacterial Agents; Bacillus cereus; Bacteremia; Cross Infection; DNA Fingerprinting; DNA, Bacterial; Fatal Outcome; Female; Humans; Imipenem; Intensive Care Units; Lung Neoplasms; Microbial Sensitivity Tests; Middle Aged; Thienamycins; Vancomycin | 2000 |
Characterization of a nosocomial outbreak caused by a multiresistant Acinetobacter baumannii strain with a carbapenem-hydrolyzing enzyme: high-level carbapenem resistance in A. baumannii is not due solely to the presence of beta-lactamases.
Topics: Acinetobacter; Acinetobacter Infections; Adult; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; beta-Lactamases; Carbapenems; Child; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Drug Resistance, Multiple; Electrophoresis, Gel, Pulsed-Field; Humans; Hydrolysis; Imipenem; Meropenem; Microbial Sensitivity Tests; Polymerase Chain Reaction; Thienamycins | 2000 |
Ability of laboratories to detect emerging antimicrobial resistance in nosocomial pathogens: a survey of project ICARE laboratories.
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Enterococcus faecium; Erythromycin; Humans; Imipenem; Laboratories, Hospital; Meropenem; Ofloxacin; Oxacillin; Penicillins; Pseudomonas aeruginosa; Reproducibility of Results; Serratia marcescens; Staphylococcus aureus; Streptococcus pneumoniae; Thienamycins; Vancomycin | 2000 |
An outbreak of imipenem-resistant Acinetobacter baumannii in critically ill surgical patients.
Topics: Acinetobacter; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Case-Control Studies; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Female; Humans; Imipenem; Intensive Care Units; Male; Middle Aged; Risk Factors | 2001 |
PCR-based DNA fingerprinting (REP-PCR, AP-PCR) and pulsed-field gel electrophoresis characterization of a nosocomial outbreak caused by imipenem- and meropenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter; Acinetobacter Infections; Cross Infection; Disease Outbreaks; DNA Fingerprinting; DNA, Bacterial; Drug Resistance, Microbial; Drug Resistance, Multiple; Electrophoresis, Gel, Pulsed-Field; Humans; Imipenem; Meropenem; Polymerase Chain Reaction; Polymorphism, Genetic; Spain; Thienamycins | 2000 |
Case-control study of risk factors for the development of enterococcal bacteremia.
Topics: Adult; Aged; Bacteremia; Case-Control Studies; Catheters, Indwelling; Cephalosporins; Cross Infection; Enterococcus; Female; Humans; Imipenem; Incidence; Male; Middle Aged; Multivariate Analysis; Neutropenia; Prospective Studies; Risk Factors; Statistics, Nonparametric; Thienamycins | 2001 |
[Activity of imipenem and meropenem against strains of Acinetobacter baumannii isolated from various Chilean hospitals].
Topics: Acinetobacter; Acinetobacter Infections; Chile; Cross Infection; Humans; Imipenem; Meropenem; Thienamycins | 2000 |
Nosocomial transmission of imipenem-resistant Pseudomonas aeruginosa following bronchoscopy associated with improper connection to the Steris System 1 processor.
Topics: Bronchoscopes; Cross Infection; Disease Outbreaks; Disinfection; Drug Resistance, Bacterial; Equipment Contamination; Female; Hospitals, Teaching; Humans; Imipenem; Male; New York City; Pseudomonas aeruginosa; Pseudomonas Infections; Sputum; Thienamycins | 2001 |
Clonal spread of imipenem-resistant Pseudomonas aeruginosa in the intensive care unit of a Turkish hospital.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Case-Control Studies; Child; Child, Preschool; Clone Cells; Cross Infection; DNA Primers; DNA, Bacterial; Drug Resistance; Female; Humans; Imipenem; Infant; Intensive Care Units; Length of Stay; Male; Middle Aged; Polymerase Chain Reaction; Pseudomonas aeruginosa; Risk Factors; Thienamycins; Turkey | 2001 |
Antibiotic resistance and molecular typing of Pseudomonas aeruginosa: focus on imipenem.
Topics: Bacterial Typing Techniques; Brazil; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genotype; Hospitals; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Diseases; Restriction Mapping; Thienamycins | 2002 |
Efficacy of teicoplanin and imipenem on respiratory infections in high risk patients.
Topics: Acinetobacter Infections; Anti-Bacterial Agents; Cross Infection; Drug Therapy, Combination; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas Infections; Risk Factors; Staphylococcal Infections; Teicoplanin; Thienamycins | 1991 |
[Evolution of the bacteria responsible for surgical infection. n 8-year study in our department].
Topics: Amikacin; Ampicillin Resistance; Bacteria; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Humans; Imipenem; Penicillin Resistance; Surgical Procedures, Operative; Time Factors | 1992 |
Resistance to imipenem among selected gram-negative bacilli in the United States.
Topics: Ceftazidime; Cross Infection; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae Infections; Humans; Imipenem; Logistic Models; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; United States | 1992 |
[Methicillin resistant Staphylococcus aureus].
Topics: Anti-Bacterial Agents; Cross Infection; Humans; Imipenem; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1992 |
Pharmacokinetic evidence of imipenem efficacy in the treatment of Klebsiella pneumoniae nosocomial meningitis.
Topics: Aged; Cross Infection; Humans; Imipenem; Klebsiella Infections; Male; Meningitis, Bacterial | 1991 |
Pharmacokinetics of imipenem/cilastatin during continuous arteriovenous hemofiltration.
Topics: Acute Kidney Injury; Adult; Aged; Bacterial Infections; Cilastatin; Cross Infection; Drug Therapy, Combination; Female; Half-Life; Hemofiltration; Humans; Imipenem; Male; Metabolic Clearance Rate; Middle Aged | 1991 |
[Resistance of hospital flora to imipenem. Experience in two intensive care units].
Topics: Acinetobacter; Cross Infection; Drug Resistance, Microbial; Escherichia coli; France; Humans; Imipenem; In Vitro Techniques; Intensive Care Units; Klebsiella pneumoniae; Pseudomonas aeruginosa; Serratia marcescens | 1991 |
[Changes in resistance of Pseudomonas aeruginosa to beta-lactams in a general intensive care unit over a three-year period. Role of piperacillin].
Topics: Cefsulodin; Ceftazidime; Cross Infection; Drug Resistance, Microbial; Female; Humans; Imipenem; Intensive Care Units; Male; Middle Aged; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Ticarcillin | 1991 |
Changes in clinically separated strains of glucose non-fermented gram-negative bacilli following the induction of imipenem/cilastatin.
Topics: Bacterial Infections; Cilastatin; Cross Infection; Fermentation; Glucose; Gram-Negative Bacteria; Humans; Imipenem; Retrospective Studies | 1991 |
Comparative in vitro activity of the new quinolone sparfloxacin (CI-978, AT-4140) against nosocomial gram-negative bloodstream isolates.
Topics: Amikacin; Anti-Infective Agents; Cephalosporins; Ciprofloxacin; Cross Infection; Enterobacteriaceae; Fluoroquinolones; Gram-Negative Bacteria; Humans; Imipenem; Pseudomonas aeruginosa; Sepsis; Tobramycin | 1990 |
[In vitro activity of imipenem against hospital bacteria].
Topics: Acinetobacter; Bacteria, Anaerobic; Cross Infection; Dose-Response Relationship, Drug; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Positive Bacteria; Imipenem; In Vitro Techniques; Pseudomonas | 1990 |
[Drug therapy of intractable methicillin-resistant staphylococcal infections].
Topics: Cefotiam; Cross Infection; Drug Therapy, Combination; Glycopeptides; Humans; Imipenem; Methicillin Resistance; Minocycline; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin | 1990 |
Nosocomial infection caused by Xanthomonas maltophilia: a case-control study of predisposing factors.
Topics: Bacterial Infections; Case-Control Studies; Cross Infection; Female; Hospitalization; Humans; Imipenem; Male; Middle Aged; Retrospective Studies; Risk Factors; Sex Factors; Trimethoprim, Sulfamethoxazole Drug Combination; Xanthomonas | 1990 |
Transductional analysis of imipenem-ceftazidime-and azactam resistant Pseudomonas aeruginosa strains from nosocomial infections.
Topics: Aztreonam; Ceftazidime; Cross Infection; Drug Resistance, Microbial; Humans; Hydrolysis; Imipenem; Pseudomonas aeruginosa; Pseudomonas Infections; Transduction, Genetic | 1989 |
[In vitro effect of antibiotics against hospital strains of Acinetobacter baumanii].
Topics: Acinetobacter; Anti-Bacterial Agents; Cross Infection; Drug Therapy, Combination; Humans; Imipenem; Microbial Sensitivity Tests; Netilmicin; Ticarcillin | 1989 |
[Selection of resistant variants by broad spectrum beta-lactam antibiotics: to what extent is there cross resistance between imipenem and other beta-lactam antibiotics?].
Topics: Anti-Bacterial Agents; Bacterial Infections; Cross Infection; Drug Resistance, Microbial; Humans; Imipenem; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins | 1986 |
In vitro susceptibility of nosocomial Pseudomonas aeruginosa, enterobacteriaceae, and staphylococci to ciprofloxacin and ten other broad-spectrum antibiotics.
Topics: Aminoglycosides; Anti-Bacterial Agents; Ciprofloxacin; Citrobacter; Cross Infection; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae; Humans; Imipenem; Microbial Sensitivity Tests; Oxacillin; Pseudomonas aeruginosa; Serratia; Staphylococcus; Thienamycins | 1987 |
Imipenem/cilastatin in the treatment of severe hospital infections.
Topics: Adult; Aged; Amikacin; Cilastatin; Cross Infection; Cyclopropanes; Dipeptidases; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Middle Aged; Thienamycins | 1988 |
Imipenem/cilastatin in the treatment of severe nosocomial pneumonia.
Topics: Adolescent; Adult; Aged; Cilastatin; Cross Infection; Dipeptidases; Drug Combinations; Drug Evaluation; Female; Humans; Imipenem; Injections, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia | 1988 |
Imipenem-cilastatin. A new dimension.
Topics: Adolescent; Adult; Aged; Cilastatin; Cross Infection; Drug Combinations; Female; Humans; Imipenem; Male; Middle Aged; Pneumonia | 1988 |
In-vitro activity of cefpirome (HR-810), WIN-49375, BMY-28142 and other antibiotics against nosocomially important isolates from cancer patients.
Topics: Anti-Bacterial Agents; Cefepime; Cefpirome; Cephalosporins; Ciprofloxacin; Cross Infection; Fluoroquinolones; Gram-Negative Bacteria; Humans; Imipenem; Microbial Sensitivity Tests; Neoplasms; Quinolines; Thienamycins | 1986 |
Comparative in vitro activities of amoxicillin-clavulanic acid and imipenem against anaerobic bacteria isolated from community hospitals.
Topics: Amoxicillin; Bacteria, Anaerobic; Clavulanic Acid; Clavulanic Acids; Cross Infection; Hospitals, Community; Humans; Imipenem; Microbial Sensitivity Tests; Thienamycins | 1986 |
Nosocomial and nursing home-acquired pneumonia. Recent therapeutic advances.
Topics: Anti-Bacterial Agents; Aztreonam; Cephalosporins; Cilastatin; Clavulanic Acid; Clavulanic Acids; Cross Infection; Cyclopropanes; Humans; Imipenem; Nursing Homes; Pneumonia; Thienamycins; Ticarcillin | 1987 |
Experience with imipenem/cilastatin in the intensive care unit.
Topics: Adolescent; Adult; Aged; Cilastatin; Critical Care; Cross Infection; Cyclopropanes; Dipeptidases; Female; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Thienamycins | 1986 |
Evaluation of imipenem/cilastatin against nosocomial infections and multiresistant pathogens.
Topics: Adult; Aged; Bacteria; Cilastatin; Cross Infection; Cyclopropanes; Dipeptidases; Drug Resistance, Microbial; Female; Humans; Imipenem; Male; Middle Aged; Thienamycins | 1986 |
In-vitro antibacterial activity of imipenem compared with four other beta-lactam antibiotics (ceftazidime, cefotaxime, piperacillin and azlocillin) against 828 separate clinical isolates from a Portuguese hospital.
Topics: Anti-Bacterial Agents; Bacteria; Cross Infection; Humans; Imipenem; Microbial Sensitivity Tests; Portugal; Thienamycins | 1986 |
Clinical outcome of nosocomial pneumonia following imipenem/cilastatin therapy.
Topics: Adult; Cilastatin; Cross Infection; Cyclopropanes; Female; Humans; Imipenem; Male; Middle Aged; Pneumonia; Thienamycins | 1987 |
Hospital acquired native valve endocarditis caused by Acinetobacter calcoaceticus and treated with imipenem/cilastin.
Topics: Acinetobacter Infections; Adult; Aortic Valve; Burns; Cilastatin; Cross Infection; Cyclopropanes; Drug Resistance, Microbial; Drug Therapy, Combination; Endocarditis, Bacterial; Humans; Imipenem; Male; Military Personnel; Sepsis; Thienamycins; Wound Infection | 1987 |
Imipenem/cilastatin: monotherapy of hospital infections.
Topics: Anti-Bacterial Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Cross Infection; Cyclopropanes; Drug Combinations; Humans; Imipenem; Thienamycins | 1987 |
[Comparative activity in vitro of ceftizoxime, ceftazidime and imipenem against Acinetobacter calcoaceticus].
Topics: Acinetobacter; Acinetobacter Infections; Cefotaxime; Ceftazidime; Ceftizoxime; Cross Infection; Humans; Imipenem; Thienamycins | 1986 |
[Treatment of respiratory tract infections with imipenem/cilastatin in critical patients with respiratory insufficiency].
Topics: Adolescent; Adult; Aged; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Cross Infection; Cyclopropanes; Drug Combinations; Female; Humans; Imipenem; Male; Middle Aged; Prospective Studies; Respiration, Artificial; Respiratory Insufficiency; Respiratory Tract Infections; Thienamycins | 1986 |
Pneumonia treated with imipenem/cilastatin.
Topics: Adult; Aged; Bacteria; Bacterial Infections; Cilastatin; Cross Infection; Cyclopropanes; Drug Combinations; Female; Humans; Imipenem; Male; Middle Aged; Pneumonia; Pseudomonas Infections; Thienamycins | 1985 |